<!DOCTYPE html><html lang="en-GB"><head><meta charSet="utf-8"/><meta http-equiv="x-ua-compatible" content="ie=edge"/><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/><style data-href="/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css" id="gatsby-global-css">.page-header{margin:0 0 3rem}.page-header__pre-heading{font-size:1.125rem;line-height:1.5rem;display:block;margin:0}.page-header__heading{font-size:2.75rem;line-height:3.5rem;margin:0 0 .5rem}.page-header__lead{font-size:1.25rem;line-height:1.75rem;margin:0 0 .5rem}.page-header__cta{font-size:1rem;line-height:1.5rem;display:block;margin:0}@media print{.page-header__cta{display:none!important}}.breadcrumbs{font-size:1rem;line-height:1.5rem;list-style:none;margin:.5em 0 2em;max-width:100%;padding:0}@media print{.breadcrumbs{display:none!important}}.breadcrumbs__crumb{display:inline-block}.breadcrumbs__crumb:before{content:">";font-size:80%;margin:0 .25em}.breadcrumbs__crumb:first-child:before{display:none}.breadcrumbs a{color:#222;text-decoration:underline}.breadcrumbs a:hover{text-decoration:none}.breadcrumbs a:focus{color:#005ea5}.breadcrumbs a:active{color:#222}.OldIEMessage-module--container--2Z9pT{max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);margin:auto auto 1rem}.OldIEMessage-module--alert--3CB3M{background:#ffdfa4;border:1px solid #966f2f;margin:1rem auto 0;max-width:73.125rem;padding:1rem}.OldIEMessage-module--alert--3CB3M a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.OldIEMessage-module--alert--3CB3M a:visited{color:#4c2c92}.OldIEMessage-module--alert--3CB3M a:hover{color:#2e8aca}.OldIEMessage-module--alert--3CB3M a:focus{outline:.25rem solid #0092a6;color:#005ea5}.OldIEMessage-module--alert--3CB3M a:active{color:#222}.OldIEMessage-module--alert--3CB3M h2{margin-top:0}.OldIEMessage-module--alert--3CB3M h2,.OldIEMessage-module--alert--3CB3M p{max-width:600px}.OldIEMessage-module--lastP---CQws{margin-bottom:0}.CoronaMessage-module--wrapper--zRiaV{background:#ffeb3b;padding:.5rem 0}.CoronaMessage-module--wrapper--zRiaV p{margin-top:0}.CoronaMessage-module--wrapper--zRiaV a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.CoronaMessage-module--wrapper--zRiaV a:visited{color:#4c2c92}.CoronaMessage-module--wrapper--zRiaV a:hover{color:#2e8aca}.CoronaMessage-module--wrapper--zRiaV a:focus{outline:.25rem solid #0092a6;color:#005ea5}.CoronaMessage-module--wrapper--zRiaV a:active{color:#222}@media print{.CoronaMessage-module--wrapper--zRiaV{display:none}}.CoronaMessage-module--container--36Biz{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.CoronaMessage-module--container--36Biz>:last-child{margin-bottom:0}.SubNav-module--wrapper--yAXWY{background:#fff;color:#000;display:block}.SubNav-module--list--1K9bK{margin:0;padding:0}.SubNav-module--list--1K9bK li{list-style:none;margin:0}.SubNav-module--link--39i23{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222;display:block;font-weight:400;padding:.5rem 1rem .5rem 2rem;text-decoration:none}.SubNav-module--link--39i23:focus{color:#222;outline:.25rem solid #0092a6;outline-offset:-.5rem}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222}.SubNav-module--link--39i23:hover{background:#d6d6d6;color:#222;text-decoration:underline}.SubNav-module--imageLink--3xwIS{display:none}@media(min-width:56.25em){.SubNav-module--wrapper--yAXWY{border-bottom:.125rem solid #004650;bottom:0;height:3rem;left:0;position:absolute;width:100%}.SubNav-module--imageLink--3xwIS{display:inline-block}.SubNav-module--list--1K9bK{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);height:100%}.SubNav-module--list--1K9bK li{display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23{border:0;display:block;height:100%;padding:0 1rem}.SubNav-module--link--39i23[aria-current=page],.SubNav-module--link--39i23[aria-current=true]{background:transparent}.SubNav-module--link--39i23[aria-current=page]:after,.SubNav-module--link--39i23[aria-current=true]:after{display:none}.SubNav-module--link--39i23:before{content:"";display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border:0}}.SubNav-module--image--uq-a2{height:100%}.Nav-module--link--3JzDA .Nav-module--tooltip--1Uj-W{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Nav-module--link--3JzDA:focus-visible .Nav-module--tooltip--1Uj-W{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Nav-module--visuallyHidden--ORHqX{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Nav-module--wrapper--2_xng{display:none;position:relative}@media print{.Nav-module--wrapper--2_xng{display:none!important}}@media(min-width:56.25em){.Nav-module--wrapper--2_xng{display:block}}.Nav-module--wrapperExpanded--3RxQB{display:block}.Nav-module--nav--2aQpa abbr[title]{border-bottom:0;cursor:help;text-decoration:none}.Nav-module--myAccount--3lsif{border-top:1px solid #fff}@media(min-width:56.25em){.Nav-module--myAccount--3lsif{display:none}}.Nav-module--myAccountHeading--1A5_B{border:.25rem solid #004650;font-size:100%;margin:0;padding:.5rem 1rem}.Nav-module--menuWrapper--2fp8S{background:#004650;color:#fff;padding:.25rem 0}.Nav-module--menuList--264L-{list-style:none;margin:auto;padding:0}.Nav-module--menuList--264L->li{margin:0}a.Nav-module--link--3JzDA{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#fff;display:block;font-weight:400;padding:.5rem 1rem;text-decoration:none}a.Nav-module--link--3JzDA span{text-decoration:inherit}a.Nav-module--link--3JzDA:focus{color:#fff;outline:.25rem solid #fff;outline-offset:-.5rem;z-index:1}a.Nav-module--link--3JzDA:visited{color:#fff}a.Nav-module--link--3JzDA:active{background:#acadad;color:#222}a.Nav-module--link--3JzDA:hover{background:#d6d6d6;color:#222;text-decoration:underline}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{background:#fff;color:#222;font-weight:700}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-color:#0092a6;outline-offset:-.25rem}@media(min-width:56.25em){.Nav-module--wrapperWithSubLinks--3PUfX{padding-bottom:3rem}.Nav-module--menuList--264L-{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);display:-webkit-flex;display:flex;-webkit-flex-direction:row;flex-direction:row;-webkit-flex-wrap:nowrap;flex-wrap:nowrap;-webkit-justify-content:space-between;justify-content:space-between}.Nav-module--menuList--264L->li{-webkit-flex-grow:1;flex-grow:1}a.Nav-module--link--3JzDA{border-left-width:0;border-right-width:0;display:-webkit-flex;display:flex;-webkit-flex-direction:column;flex-direction:column;height:100%;-webkit-justify-content:center;justify-content:center;line-height:1.25;margin:0;padding:.5rem;position:relative;text-align:center}a.Nav-module--link--3JzDA:focus{outline-offset:-.25rem}a.Nav-module--link--3JzDA span{display:inline-block;vertical-align:middle;white-space:normal}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{margin:0 .25rem}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-offset:-.5rem}a.Nav-module--link--3JzDA[aria-current=page]:after,a.Nav-module--link--3JzDA[aria-current=true]:after{background:#fff;content:"";display:block;height:.25rem;left:0;position:absolute;top:100%;width:100%}a.Nav-module--link--3JzDA[aria-current=page]:hover:after,a.Nav-module--link--3JzDA[aria-current=true]:hover:after{background:#d6d6d6}}@media(min-width:56.25em)and (min-width:75em){a.Nav-module--link--3JzDA{padding:1rem}}.Autocomplete-module--ac--2PqiF .autocomplete__wrapper{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input{-webkit-appearance:none;border:1px solid #222;border-radius:0;box-sizing:border-box;margin-bottom:0;width:100%}.Autocomplete-module--ac--2PqiF .autocomplete__input{background-color:#e9e9e9!important;height:2.5rem!important;margin:0!important;max-width:100%!important;position:relative;z-index:101}.Autocomplete-module--ac--2PqiF .autocomplete__input:focus{outline:3px solid #0092a6;outline-offset:-3px;z-index:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-webkit-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-moz-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input:-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__hint{color:#bfc1c3;position:absolute}.Autocomplete-module--ac--2PqiF .autocomplete__input--default{padding:.5rem}.Autocomplete-module--ac--2PqiF .autocomplete__input--focused{outline:3px solid #0092a6;outline-offset:-3px}.Autocomplete-module--ac--2PqiF .autocomplete__input--show-all-values{padding:4px 34px 4px 4px;cursor:pointer}.Autocomplete-module--ac--2PqiF .autocomplete__dropdown-arrow-down{z-index:-1;display:inline-block;position:absolute;right:8px;width:24px;height:24px;top:10px}.Autocomplete-module--ac--2PqiF .autocomplete__menu{background-color:#fff;border:1px solid #d6d6d6;border-top:0;color:#34384b;margin:0;max-width:100%;padding:0;text-align:left;width:-webkit-calc(100vw - 2rem);width:calc(100vw - 2rem)}@media(min-width:37.5em){.Autocomplete-module--ac--2PqiF .autocomplete__menu{width:100%}}.Autocomplete-module--ac--2PqiF .autocomplete__menu--visible{display:block}.Autocomplete-module--ac--2PqiF .autocomplete__menu--hidden{display:none}.Autocomplete-module--ac--2PqiF .autocomplete__menu--overlay{box-shadow:0 .25rem 1rem .25rem rgba(0,0,0,.1);left:0;position:absolute;top:100%;z-index:100}.Autocomplete-module--ac--2PqiF .autocomplete__menu--inline{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option{border-left-width:0;border-bottom:1px solid #d6d6d6;border-right-width:0;border-top-width:1px;color:#005ea5;cursor:pointer;display:block;margin:0;position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option a{color:inherit;display:block;font-weight:400;padding:.5rem;text-decoration:none}.Autocomplete-module--ac--2PqiF .autocomplete__option mark{background:0;color:inherit;font-weight:700;padding:0}.Autocomplete-module--ac--2PqiF .autocomplete__option>*{pointer-events:none}.Autocomplete-module--ac--2PqiF .autocomplete__option:first-of-type{border-top-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option:last-of-type{border-bottom-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option--odd{background-color:#fafafa}.Autocomplete-module--ac--2PqiF .autocomplete__option--focused,.Autocomplete-module--ac--2PqiF .autocomplete__option:hover{background-color:#e9e9e9;color:#005ea5;outline:none;text-decoration:underline}.Autocomplete-module--ac--2PqiF .autocomplete__option--no-results{background-color:#fafafa;color:#646b6f;cursor:not-allowed}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input,.Autocomplete-module--ac--2PqiF .autocomplete__option{font-size:16px;line-height:1.25}.Search-module--search--2wNll{margin:0;padding-right:2.5rem;position:relative}.Search-module--label--1rrog{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute!important;width:1px}.Search-module--button--2FbnI{background:#393939;border:0;color:#fff;cursor:pointer;height:2.5rem;min-width:2.5rem;padding:0 .5rem;position:absolute;right:0;text-align:center;top:0;z-index:101}.Search-module--button--2FbnI:focus{outline:.25rem solid #0092a6}.Search-module--button--2FbnI .Search-module--icon--2JB42{font-size:150%;vertical-align:middle}.Account-module--account--1BtRh{position:relative}.Account-module--button--zZii1{background:#fff;border:1px solid #222;color:#222;cursor:pointer;display:inline-block;font-family:inherit;font-size:inherit;font-weight:400;height:2.5rem;line-height:2.5rem;padding:0 .5rem;text-decoration:none;vertical-align:middle;white-space:nowrap}.Account-module--button--zZii1:focus{outline:.25rem solid #0092a6}.Account-module--button--zZii1:visited{color:#222}.Account-module--button--zZii1:hover{border:1px solid #222}.Account-module--myAccount--3jTaq:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Account-module--myAccount--3jTaq[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Account-module--menu--3C46i{background:#fff;border:1px solid #393939;list-style:none;margin:.625rem 0 0;padding:0;position:absolute;right:0;top:100%;z-index:2}.Account-module--menu--3C46i:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i[aria-hidden=true]{display:none}.Account-module--menu--3C46i:before{border-bottom:.5rem solid #393939;border-left:.25rem solid transparent;border-right:.25rem solid transparent}.Account-module--menu--3C46i:after,.Account-module--menu--3C46i:before{bottom:100%;content:"";display:block;height:0;position:absolute;right:1rem;width:0}.Account-module--menu--3C46i:after{border-bottom:.4rem solid #fff;border-left:.2rem solid transparent;border-right:.2rem solid transparent;margin-right:1px}.Account-module--menu--3C46i li{border-top:1px solid #d6d6d6;list-style:none;margin:0}.Account-module--menu--3C46i a{color:#005ea5;display:block;padding:.5rem 1rem;text-decoration:none;white-space:nowrap}.Account-module--menu--3C46i a:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i a:hover{background:#e9e9e9;text-decoration:underline}.Header-module--header--3os44{background:#fff;border-bottom:.125rem solid #004650;box-sizing:border-box;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif}.Header-module--header--3os44 *,.Header-module--header--3os44 :after,.Header-module--header--3os44 :before{box-sizing:inherit;font-family:inherit}@media print{.Header-module--header--3os44{border-bottom:none}}.Header-module--container--1mfIr{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0 0}.Header-module--container--1mfIr:after{clear:both;content:"";display:table}.Header-module--home--1TCPb{color:#000;display:inline-block;float:left;height:1.875rem;margin-bottom:1rem}@media print{.Header-module--home--1TCPb:after{content:none!important}}.Header-module--home--1TCPb:focus{outline:.25rem solid #0092a6}.Header-module--home--1TCPb:visited{color:#000}.Header-module--home--1TCPb .Header-module--icon--4LSt5{height:100%;width:auto}.Header-module--wrapper--2e13D{display:-webkit-flex;display:flex;-webkit-flex-grow:1;flex-grow:1;float:right;-webkit-justify-content:space-between;justify-content:space-between;margin-bottom:1rem;width:50%}@media print{.Header-module--wrapper--2e13D{display:none!important}}.Header-module--wrapper--2e13D:after{clear:both;content:"";display:table}.Header-module--search--2nfnz{-webkit-flex-grow:1;flex-grow:1;float:left;margin-right:1rem;min-width:66.6666666667%}.Header-module--mobileMenuBtn--1LgyL{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:1px solid #222;float:right;font-family:inherit;font-size:110%;height:2.5rem;min-width:4.6875rem;white-space:nowrap}.Header-module--mobileMenuBtn--1LgyL:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Header-module--mobileMenuBtn--1LgyL[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Header-module--account--y72Q4{display:none}@media(max-width:56.24em){.Header-module--home--1TCPb{float:none}.Header-module--wrapper--2e13D{float:none;width:auto}}@media(min-width:56.25em){.Header-module--header--3os44{border-bottom:.25rem solid #fff}.Header-module--container--1mfIr{display:-webkit-flex;display:flex;-webkit-justify-content:space-between;justify-content:space-between}.Header-module--home--1TCPb{height:2.5rem;margin-right:2rem}.Header-module--wrapper--2e13D{-webkit-justify-content:flex-end;justify-content:flex-end}.Header-module--search--2nfnz{margin-right:2rem}.Header-module--mobileMenuBtn--1LgyL{display:none}.Header-module--account--y72Q4{display:block}}.SkipLinks-module--list--1WwLa{list-style:none;margin:0;padding:0}@media print{.SkipLinks-module--list--1WwLa{display:none!important}}.SkipLinks-module--list--1WwLa li{list-style:none;margin:0}.SkipLinks-module--link--hkZw8{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.SkipLinks-module--link--hkZw8:focus{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;left:.25rem;outline:3px solid #0092a6;overflow:visible;padding:.5rem 1rem;position:absolute;top:.25rem;white-space:nowrap;width:auto;z-index:1}.Social-module--wrapper--2nKsd{clear:left}.Social-module--list--E5R5J{list-style:none;margin:0;max-width:100%;padding:0}.Social-module--list--E5R5J li{margin:0 0 .25rem}.Social-module--list--E5R5J svg{margin:-.125rem .25rem 0 0;vertical-align:middle}@media(min-width:37.5em){.Social-module--list--E5R5J li{float:left;margin:0 1rem 0 0}}@media(min-width:56.25em){.Social-module--wrapper--2nKsd{clear:none}.Social-module--wrapper--2nKsd li{float:none;margin:0 0 .25rem}}.Legal-module--wrapper--3AYMO{font-size:.875rem;line-height:1.25rem;background:#393939;padding:1rem 0}.Legal-module--wrapper--3AYMO a{text-decoration:underline}.Legal-module--container--3TTBh{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.Legal-module--menu--1e1Iy{margin:0 0 1rem}@media print{.Legal-module--menu--1e1Iy{display:none!important}}.Legal-module--menu--1e1Iy ul{list-style:none;margin:0;max-width:100%;padding:0}.Legal-module--menu--1e1Iy li{margin:0}.Legal-module--menu--1e1Iy a{display:block}.Legal-module--copyright--34nsI{font-size:.875rem;line-height:1.25rem;margin:0}@media print{.Legal-module--copyright--34nsI{float:none!important;max-width:100%}}@media(min-width:37.5em){.Legal-module--menu--1e1Iy li{display:inline-block;margin-right:1rem}}@media(min-width:75em){.Legal-module--wrapper--3AYMO:after,.Legal-module--wrapper--3AYMO:before{content:" ";display:table}.Legal-module--wrapper--3AYMO:after{clear:both}.Legal-module--menu--1e1Iy{float:left;margin:0}.Legal-module--copyright--34nsI{float:right}}.Services-module--link--2y_1q .Services-module--tooltip--pg3nW{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Services-module--link--2y_1q:focus-visible .Services-module--tooltip--pg3nW{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Services-module--visuallyHidden--t9mfm{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Services-module--wrapper--2qOoE{margin:0 0 2rem}.Services-module--list--3SZQu{list-style:none;margin:0;padding:0}.Services-module--list--3SZQu li{margin:0 0 .25rem}@media(min-width:37.5em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;width:33.3333333333%}}@media(min-width:56.25em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;margin:0;width:25%}}.Pages-module--wrapper--30REl{margin:0 0 2rem}.Pages-module--list--vvSk4{list-style:none;margin:0;padding:0}.Pages-module--list--vvSk4 li{margin:0 0 .25rem}@media(min-width:25em){.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}@media(min-width:37.5em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 0 0 2rem;width:66.6666666667%}}@media(min-width:56.25em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 2rem;width:50%}.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}.Footer-module--link--CGIYk .Footer-module--tooltip--1zoJv{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Footer-module--link--CGIYk:focus-visible .Footer-module--tooltip--1zoJv{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Footer-module--visuallyHidden--3CCnP{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Footer-module--footer--2QrGZ{background:#222;box-sizing:border-box;color:#fff;contain-intrinsic-size:350px;content-visibility:auto;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;margin:2rem 0 0}.Footer-module--footer--2QrGZ a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.Footer-module--footer--2QrGZ a:visited{color:#fff}.Footer-module--footer--2QrGZ a:hover{color:#d6d6d6}.Footer-module--footer--2QrGZ a:focus{outline:.25rem solid #fff;color:#fff}.Footer-module--footer--2QrGZ a:active{color:#d6d6d6}.Footer-module--footer--2QrGZ *,.Footer-module--footer--2QrGZ :after,.Footer-module--footer--2QrGZ :before{box-sizing:inherit}.Footer-module--footer--2QrGZ a{font-weight:400}.Footer-module--container--1iuoB{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0}.Footer-module--container--1iuoB:after,.Footer-module--container--1iuoB:before{content:" ";display:table}.Footer-module--container--1iuoB:after{clear:both}@media print{.Footer-module--container--1iuoB{display:none!important}}.Footer-module--logo--3DGKv{display:block;height:0;margin:0 0 2rem;padding:0 0 29.0496453901px;position:relative;width:80px}.Footer-module--logo--3DGKv svg{display:block;height:100%!important;left:0;position:absolute;top:0;width:100%!important}@media(min-width:56.25em){.Footer-module--logo--3DGKv{margin-bottom:1rem}}.BackToTop-module--wrapper--2Z0EU{margin-top:3rem}@media print{.BackToTop-module--wrapper--2Z0EU{display:none}}.BackToTop-module--nav--1DPZ6{background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}.BackToTop-module--anchor--1Nia6{display:block;line-height:1rem;padding:1rem 0}.BackToTop-module--anchor--1Nia6:visited{color:#005ea5}.BackToTop-module--anchor--1Nia6 svg{-webkit-transition:all .25s ease;transition:all .25s ease}.BackToTop-module--anchor--1Nia6:hover{background:#f4f4f4}.BackToTop-module--anchor--1Nia6:hover svg{-webkit-transform:translateY(-.125rem);transform:translateY(-.125rem)}@supports((position:-webkit-sticky) or (position:sticky)){.BackToTop-module--wrapper--2Z0EU{bottom:0;left:0;margin:0;pointer-events:none;position:absolute;right:0;top:min(100vh,-webkit-calc(100% - 3rem));top:min(100vh,calc(100% - 3rem));width:100%;z-index:99}.BackToTop-module--nav--1DPZ6{position:-webkit-sticky;position:sticky;pointer-events:all;top:-webkit-calc(100vh - 3rem);top:calc(100vh - 3rem);background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-regular.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-regular.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:italic;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-italic.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-italic.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:700;src:local("Lato"),url(../../../../fonts/lato-v17-latin-700.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-700.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:900;src:local("Lato"),url(../../../../fonts/lato-v17-latin-900.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-900.woff) format("woff")}/*! normalize.css v8.0.1 | MIT License | github.com/necolas/normalize.css */html{line-height:1.15;-webkit-text-size-adjust:100%}body{margin:0}main{display:block}h1{font-size:2em;margin:.67em 0}hr{box-sizing:content-box;height:0;overflow:visible}pre{font-family:monospace,monospace;font-size:1em}a{background-color:transparent}abbr[title]{border-bottom:none;text-decoration:underline;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b,strong{font-weight:bolder}code,kbd,samp{font-family:monospace,monospace;font-size:1em}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sub{bottom:-.25em}sup{top:-.5em}img{border-style:none}button,input,optgroup,select,textarea{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=button],[type=reset],[type=submit],button{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}fieldset{padding:.35em .75em .625em}legend{box-sizing:border-box;color:inherit;display:table;max-width:100%;padding:0;white-space:normal}progress{vertical-align:baseline}textarea{overflow:auto}[type=checkbox],[type=radio]{box-sizing:border-box;padding:0}[type=number]::-webkit-inner-spin-button,[type=number]::-webkit-outer-spin-button{height:auto}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}[type=search]::-webkit-search-decoration{-webkit-appearance:none}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}details{display:block}summary{display:list-item}[hidden],template{display:none}.show-print{display:none!important}@media print{.show-print{display:block!important}}@media print{.hide-print{display:none!important}}@media print{.remove-appended-print-link:after{content:none!important}}@media print{*{background:transparent!important;box-shadow:none!important;color:#000!important;text-shadow:none!important}a,a:visited{text-decoration:underline}}@media print{h1 a:after,h2 a:after,h3 a:after,h4 a:after,h5 a:after,h6 a:after{content:none!important}}@media print{a[href]:after{content:" (" attr(href) ")"}}@media print{abbr[title]:after{content:" (" attr(title) ")"}}@media print{.ir a:after,a[href^="#"]:after,a[href^="javascript:"]:after{content:""}}@media print{blockquote,pre{border:1px solid #999;page-break-inside:avoid}}@media print{thead{display:table-header-group}}@media print{img,tr{page-break-inside:avoid}}@media print{img{max-width:100%!important}}@media print{img:not([alt]),img[alt=""]{display:none!important}}@media print{@page{margin:.5cm}}@media print{h2,h3,p{orphans:3;widows:3}}@media print{h2,h3{page-break-after:avoid}}.clearfix:after,.clearfix:before{content:" ";display:table}.clearfix:after{clear:both}.container{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.container--full{max-width:100%;padding:0 2%;width:auto}html{box-sizing:border-box;font-size:.9375rem;overflow-x:hidden}html *,html :after,html :before{box-sizing:inherit}@media(min-width:56.25em){html{font-size:1.03125rem;font-size:-webkit-calc(.375rem + 1vw);font-size:calc(.375rem + 1vw)}}@media(min-width:75em){html{font-size:1.125rem}}body{background:#f4f4f4;color:#222;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;font-style:normal;line-height:1.5rem;overflow-x:hidden;text-rendering:optimizelegibility}img{max-width:100%}hr{background:0;border:0;border-top:.0625em solid #adadad;margin:2em 0;padding:0}.p,p{font-size:1rem;line-height:1.5rem;font-feature-settings:"kern","onum","liga"}.lead,.p,p{margin-bottom:1rem;margin-top:1rem;font-weight:400;max-width:66ch}.lead{font-size:1.25rem;line-height:1.75rem}code{background:#e9e9e9;border:1px solid #adadad;border-radius:.125em;color:#222;display:inline-block;font-family:Monaco,Menlo,Consolas,Courier New,monospace;margin:0 0 .125em;padding:0 .25em}pre code{background:transparent;border:0;margin:0}.mark,mark{background-color:#fff999;padding:0 .25em}.small,small{font-size:85%}.h6,h6{font-size:1rem}.h5,.h6,h5,h6{line-height:1.5rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h5,h5{font-size:1.125rem}.h4,h4{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h3,h3{font-size:1.75rem;line-height:2rem}.h2,.h3,h2,h3{margin-bottom:1rem;margin-top:2rem;clear:both;font-weight:700;max-width:66ch}.h2,h2{font-size:2.25rem;line-height:2.5rem}.h1,.h2+.h3,.h2+h3,h1,h2+.h3,h2+h3{margin-top:0}.h1,h1{font-size:2.75rem;line-height:3.5rem;margin-bottom:1rem;clear:both;font-weight:900;max-width:66ch}.h1+.h2,.h1+h2,h1+.h2,h1+h2{margin-top:0}a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a:visited{color:#4c2c92}a:hover{color:#2e8aca}a:focus{outline:.25rem solid #0092a6;color:#005ea5}a:active{color:#222}.link--inverse{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.link--inverse:visited{color:#fff}.link--inverse:hover{color:#d6d6d6}.link--inverse:focus{outline:.25rem solid #fff;color:#fff}.link--inverse:active{color:#d6d6d6}.inverse-links a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.inverse-links a:visited{color:#fff}.inverse-links a:hover{color:#d6d6d6}.inverse-links a:focus{outline:.25rem solid #fff;color:#fff}.inverse-links a:active{color:#d6d6d6}.list,ol,ul{font-feature-settings:"kern","onum","liga";margin-left:1rem;max-width:66ch;padding:0}.list--unstyled{list-style:none;margin-left:0;max-width:none;padding:0}.list--loose .list__item,.list--loose li{margin-bottom:.25rem}.list--piped{list-style:none;margin-left:0;padding:0}.list--piped .list__item,.list--piped li{display:inline-block;margin-right:-.25rem}.list--piped .list__item a,.list--piped li a{padding:.5rem}.list--piped .list__item:after,.list--piped li:after{border-left:1px solid #004650;content:"\200B";display:inline-block;margin:0 .5em;overflow:hidden;text-indent:-99px;vertical-align:middle;width:0}.list--piped .list__item:first-child a,.list--piped li:first-child a{padding-left:0}.list--piped .list__item:last-child:after,.list--piped li:last-child:after{display:none}.quote{font-size:1.25rem;line-height:1.75rem;border-left:.25em solid #004650;font-weight:400;margin:2rem 0;padding:0 0 0 4rem;position:relative}.quote:before{color:#004650;content:"\201C";display:block;font-family:Arial,sans-serif;font-size:5rem;font-weight:700;left:0;line-height:.8;position:absolute;text-align:center;top:0;width:4rem}@media print{.quote:before{color:#000}}.quote p{font-size:inherit}.quote cite,.quote footer{font-size:1rem;line-height:1.5rem;font-style:normal}table{background:#fff;border:1px solid #adadad;border-collapse:collapse;display:block;margin:0 0 1rem;max-width:100%;overflow-y:hidden;overflow-x:auto;width:100%!important}table th{vertical-align:bottom}table td{vertical-align:top}table td,table th{border:1px solid #adadad;padding:.5rem;text-align:left}table td:first-child,table th:first-child{border-left:0}table td:last-child,table th:last-child{border-right:0}table td p,table th p{margin-top:0}table :not(thead)+tbody tr:first-child th,table tbody tr:first-child th,table thead tr:first-child th{border-top:0}table tbody tr:last-child td{border-bottom:0}table tbody tr:nth-child(2n)>td{background-color:#e9e9e9}html{overflow-x:visible;scroll-behavior:smooth}@media(prefers-reduced-motion){html{scroll-behavior:auto}}body{font-family:Lato,Trebuchet MS,Roboto,Helvetica Neue,Helvetica,Arial,sans-serif;position:relative}.visually-hidden{position:absolute;overflow:hidden;clip:rect(0 0 0 0);height:1px;width:1px;margin:-1px;padding:0;border:0}#content-start:focus{outline:none}footer{margin-top:0!important}@supports((position:-webkit-sticky) or (position:sticky)){.Layout-module--main--1OIFf{position:relative;padding-bottom:4rem}}.stacked-nav{background:#fff;border:1px solid #adadad;margin:0 0 2em}@media print{.stacked-nav{display:none!important}}.stacked-nav__root{font-size:1rem;line-height:1.5rem;border-bottom:1px solid #adadad;font-weight:700;margin:0;max-width:none;position:relative;text-decoration:none}.stacked-nav__root a{color:#222}.stacked-nav__root--no-link{padding:.5em}.stacked-nav__hint{color:#222;display:block}.stacked-nav__hint :active{color:#fff}.stacked-nav__list{list-style:none;margin:0;max-width:100%;padding:0}.stacked-nav__list-item{border-top:1px solid #adadad}.stacked-nav__content-wrapper{display:block}.stacked-nav a{color:#005ea5;display:block;padding:.5em;position:relative;text-decoration:none}.stacked-nav a[aria-current=page],.stacked-nav a[aria-current=true]{background:#e9e9e9;font-weight:700}.stacked-nav a[aria-current=page]:before,.stacked-nav a[aria-current=true]:before{background:#004650;content:"";display:block;height:100%;left:0;position:absolute;top:0;width:.25em}.stacked-nav a:hover{background:#d6d6d6}.stacked-nav a:active{background:#004650;color:#fff}.stacked-nav a:active span{color:#fff}.stacked-nav__nested{list-style:none;margin:0;padding:0}.stacked-nav__nested .stacked-nav__content-wrapper{padding-left:1rem!important}.stacked-nav__nested ul .stacked-nav__content-wrapper{padding-left:2rem!important}.TopicChaptersMenu-module--toggleButton--2MGXA{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:#e9e9e9;border:1px solid #adadad;color:#005ea5;cursor:pointer;display:block;margin:0 0 2rem;padding:1rem 2rem 1rem .5rem;position:relative;text-align:left;width:100%}.TopicChaptersMenu-module--toggleButton--2MGXA:focus{outline:.25rem solid #0092a6;z-index:1}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=false]+.stacked-nav{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]{border-bottom:0;margin:0}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]+.stacked-nav{display:block}@media(min-width:37.5em){.TopicChaptersMenu-module--toggleButton--2MGXA{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded]+.stacked-nav{display:block}}.TopicChaptersMenu-module--icon--27uSj{color:#005ea5;right:.5rem;position:absolute;top:50%;-webkit-transform:translateY(-50%);transform:translateY(-50%)}.ChapterContents-module--wrapper--3ONbu{position:relative}.ChapterContents-module--printBtn--Rk_Zs{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;bottom:100%;cursor:pointer;display:none;padding:0}.ChapterContents-module--printBtn--Rk_Zs:visited{color:#4c2c92}.ChapterContents-module--printBtn--Rk_Zs:hover{color:#2e8aca}.ChapterContents-module--printBtn--Rk_Zs:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterContents-module--printBtn--Rk_Zs:active{color:#222}.ChapterContents-module--printBtn--Rk_Zs svg{font-size:1.25rem;line-height:1.75rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterContents-module--printBtn--Rk_Zs:hover svg{color:#2e8aca}@media(min-width:37.5em){.ChapterContents-module--wrapper--3ONbu:after,.ChapterContents-module--wrapper--3ONbu:before{content:" ";display:table}.ChapterContents-module--wrapper--3ONbu:after{clear:both}.ChapterContents-module--menu--3Epka{float:left;margin-right:1rem;width:-webkit-calc(25% - .5rem);width:calc(25% - .5rem)}.ChapterContents-module--landing--3klSq,.ChapterContents-module--onThisPage--1333P{float:right;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + .5rem);overflow:hidden;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}}@media(min-width:56.25em){.ChapterContents-module--printBtn--Rk_Zs{display:block;margin-bottom:3rem;position:absolute;right:0}.ChapterContents-module--menu--3Epka{margin-right:2rem;width:-webkit-calc(25% - 1rem);width:calc(25% - 1rem)}.ChapterContents-module--landing--3klSq{width:-webkit-calc(75% - 1rem);width:calc(75% - 1rem)}.ChapterContents-module--onThisPage--1333P{position:-webkit-sticky;position:sticky;top:0;width:-webkit-calc(16.66667% - 1rem);width:calc(16.66667% - 1rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + 1rem);width:-webkit-calc(58.33333% - 2rem);width:calc(58.33333% - 2rem)}}@media print{.ChapterContents-module--menu--3Epka,.ChapterContents-module--onThisPage--1333P,.ChapterContents-module--printBtn--Rk_Zs{display:none}.ChapterContents-module--body--1XBoo{width:100%}}.ChapterBody-module--wrapper--2HCfk>.visually-hidden:first-child+*>:first-child{margin-top:0}.ChapterBody-module--wrapper--2HCfk h2:focus,.ChapterBody-module--wrapper--2HCfk h3:focus,.ChapterBody-module--wrapper--2HCfk h4:focus,.ChapterBody-module--wrapper--2HCfk h5:focus,.ChapterBody-module--wrapper--2HCfk h6:focus{outline:0!important}.ChapterBody-module--basisWrapper--3JBM_{border:1px solid #adadad;margin-top:1rem;max-width:66ch}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-top:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK{padding:0 1rem 1rem}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK>:last-child{margin-bottom:0}.ChapterBody-module--headerWrapper--qSIFw{padding:1rem;position:relative}.ChapterBody-module--toggleBtn--3g0p7{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;cursor:pointer;display:block;margin-top:-.5rem;padding:0}.ChapterBody-module--toggleBtn--3g0p7:visited{color:#4c2c92}.ChapterBody-module--toggleBtn--3g0p7:hover{color:#2e8aca}.ChapterBody-module--toggleBtn--3g0p7:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterBody-module--toggleBtn--3g0p7:active{color:#222}.ChapterBody-module--toggleBtn--3g0p7:after{content:"";height:100%;left:0;position:absolute;top:0;width:100%}.ChapterBody-module--toggleBtn--3g0p7 svg{font-size:1.125rem;line-height:1.5rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterBody-module--toggleBtn--3g0p7:hover svg{color:#2e8aca}.ChapterBody-module--body--2n0CK[aria-hidden=true]{display:none}@media print{.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-bottom:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK[aria-hidden=true]{display:block}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--toggleBtn--3g0p7{display:none}}.ChapterOnThisPage-module--wrapper--2zc7n{margin-bottom:2rem}.ChapterOnThisPage-module--heading--2SdDN{margin-top:0}.ChapterOnThisPage-module--rootList--2II70{list-style:disc}.ChapterOnThisPage-module--subList--Pwxy9{list-style:circle}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:none}@media(min-width:56.25em){.ChapterOnThisPage-module--heading--2SdDN{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:0}@supports((position:-webkit-sticky) or (position:sticky)){.ChapterOnThisPage-module--rootList--2II70 a[aria-current=location]{font-weight:700}.ChapterOnThisPage-module--rootList--2II70 a:focus+.ChapterOnThisPage-module--subList--Pwxy9{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--subList--Pwxy9{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.ChapterOnThisPage-module--subList--Pwxy9:focus-within{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--expandedSubList--1m1WN{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:list-item}}}</style><link rel="sitemap" type="application/xml" href="../../../../sitemap.xml"/><title data-react-helmet="true">Scenario: Pregnant: on an antidepressant | Management | Depression - antenatal and postnatal | CKS | NICE</title><link data-react-helmet="true" rel="search" type="application/opensearchdescription+xml" href="../../../../opensearch.xml" title="CKS"/><link data-react-helmet="true" rel="icon" href="../../../../favicon.ico"/><link data-react-helmet="true" rel="canonical" href="index.html"/><meta data-react-helmet="true" name="description" content="Covers the management of a woman being treated for depression who becomes pregnant."/><meta data-react-helmet="true" property="og:description" content="Covers the management of a woman being treated for depression who becomes pregnant."/><meta data-react-helmet="true" property="og:url" content="https://cks.nice.org.uk/topics/depression-antenatal-postnatal/management/pregnant-on-an-antidepressant/"/><meta data-react-helmet="true" property="og:locale" content="en_GB"/><meta data-react-helmet="true" property="og:type" content="website"/><meta data-react-helmet="true" property="og:title" content="Scenario: Pregnant: on an antidepressant | Management | Depression - antenatal and postnatal | CKS | NICE"/><meta data-react-helmet="true" property="og:image" content="https://cks.nice.org.uk/open-graph-image.png"/><meta data-react-helmet="true" property="og:image:width" content="1200"/><meta data-react-helmet="true" property="og:image:height" content="630"/><meta data-react-helmet="true" name="twitter:card" content="summary"/><meta data-react-helmet="true" name="twitter:image" content="https://cks.nice.org.uk/twitter-summary-image.png"/><meta data-react-helmet="true" name="twitter:image:alt" content="NICE and CKS logos"/><meta data-react-helmet="true" name="twitter:site" content="@NICEcomms"/><meta data-react-helmet="true" name="twitter:creator" content="@NICEcomms"/><meta data-react-helmet="true" name="theme-color" content="#004650"/><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+'';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer', 'GTM-54QC4NL');</script><link rel="manifest" href="../../../../manifest.webmanifest" crossorigin="anonymous"/><meta name="theme-color" content="#004650"/><link rel="apple-touch-icon" sizes="48x48" href="../../../../icons/icon-48x48.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="72x72" href="../../../../icons/icon-72x72.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="96x96" href="../../../../icons/icon-96x96.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="144x144" href="../../../../icons/icon-144x144.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="192x192" href="../../../../icons/icon-192x192.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="256x256" href="../../../../icons/icon-256x256.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="384x384" href="../../../../icons/icon-384x384.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="512x512" href="../../../../icons/icon-512x512.png@v=28734348209eeeae5c03a37867f1beb1"/><link as="script" rel="preload" href="../../../../webpack-runtime-28c424ef71f39faedaf0.js"/><link as="script" rel="preload" href="../../../../framework-34da02e39e1f104d9937.js"/><link as="script" rel="preload" href="../../../../app-53a71c38b210970893c4.js"/><link as="script" rel="preload" href="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js"/><link as="script" rel="preload" href="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js"/><link as="script" rel="preload" href="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"/><link as="fetch" rel="preload" href="../../../../page-data/topics/depression-antenatal-postnatal/management/pregnant-on-an-antidepressant/page-data.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/sq/d/3666801979.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/app-data.json" crossorigin="anonymous"/><script src="https://cdn.nice.org.uk/cookie-banner/cookie-banner.min.js" type="text/javascript" async=""></script></head><body><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54QC4NL" height="0" width="0" style="display: none; visibility: hidden" aria-hidden="true"></iframe></noscript><div id="___gatsby"><div style="outline:none" tabindex="-1" id="gatsby-focus-wrapper"><div><div class="Header-module--header--3os44"><header aria-label="Site header"><ul class="SkipLinks-module--list--1WwLa" aria-label="Accessibility links"><li><a href="index.html#content-start" class="SkipLinks-module--link--hkZw8">Skip to content</a></li><li><a href="https://www.nice.org.uk/accessibility" class="SkipLinks-module--link--hkZw8">Accessibility help</a></li></ul><div class="Header-module--container--1mfIr"><a href="https://www.nice.org.uk/" aria-label="Home" class="Header-module--home--1TCPb"><svg viewBox="0 0 4616 512" fill="none" class="Header-module--icon--4LSt5" aria-hidden="true" focusable="false"><path d="M1626 44v175h-22L1497 71v148h-19V44h22l107 147V44h19zm130 154a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-35 18-48 11-14 27-20 47-20 19 0 34 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm109 16V104h-27V87h27V40h19v47h30v17h-30v115h-19zm88-180v26h-21V39h21zm-20 48h20v132h-20V87zm107-2c20 0 35 6 48 20 11 12 17 28 17 48 0 19-6 36-17 48a61 61 0 01-48 20c-19 0-35-7-47-20a69 69 0 01-17-48c0-20 5-36 17-48 12-14 28-20 47-20zm0 118c14 0 25-5 34-15 7-9 11-21 11-35s-4-26-11-35c-9-10-20-15-34-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm107-116v21c5-7 11-12 18-17 6-4 14-6 23-6 8 0 16 1 22 4 6 2 12 6 17 11 10 10 16 24 16 42v77h-20v-76c0-13-3-22-10-29-7-8-16-11-26-11a38 38 0 00-40 40v76h-19V87h19zm222 111a52 52 0 01-46 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 5-35 17-48 12-14 27-20 47-20 19 0 35 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm114 16h-19V34h19v185zm108 0h-19V44h19v175zm55-132v21c5-7 10-12 17-17 7-4 15-6 23-6 9 0 17 1 23 4 6 2 12 6 16 11 11 10 16 24 16 42v77h-19v-76c0-13-4-22-10-29-7-8-16-11-27-11a38 38 0 00-39 40v76h-19V87h19zm202 35c-2-13-13-20-33-20s-30 6-30 19c0 5 2 9 6 12 5 2 10 5 16 6l21 5 21 7c7 2 12 6 16 11 5 5 7 11 7 19 0 13-5 23-15 30-9 7-22 10-38 10-18 0-32-4-42-13-9-8-14-18-15-31h20c2 13 8 21 21 25l13 2 13-1 11-3c8-3 12-9 12-17 0-5-2-9-6-12s-10-6-16-7l-21-5-21-7c-7-2-12-6-16-10-4-5-6-11-6-19 0-12 4-22 12-28 9-7 22-10 39-10 15 0 28 4 37 11 8 7 12 16 14 26h-20zm60 97V104h-26V87h26V40h20v47h30v17h-30v115h-20zm89-180v26h-21V39h21zm-21 48h20v132h-20V87zm65 132V104h-26V87h26V40h20v47h30v17h-30v115h-20zm162 0v-21c-4 7-10 12-17 16-7 5-14 7-23 7s-16-1-22-4c-7-2-12-6-17-11a57 57 0 01-16-42V87h20v76c0 12 3 22 10 29 6 7 15 11 26 11a39 39 0 0039-40V87h20v132h-20zm65 0V104h-26V87h26V40h20v47h30v17h-30v115h-20zm124-16c17 0 30-7 37-22h22c-5 12-12 22-22 29-9 7-22 11-38 11-19 0-35-7-47-20a68 68 0 01-18-48c0-20 5-36 17-48 12-14 28-20 47-20 20 0 35 6 48 20 11 12 17 28 17 48v8h-109c1 12 6 22 14 30s19 12 32 12zm-2-100c-12 0-22 4-30 11s-12 17-14 28h88c-1-11-6-21-14-28s-18-11-30-11zm195-52c-9 0-16 2-21 6-4 4-7 11-7 20v10h30v17h-30v115h-19V104h-23V87h23V75c0-14 4-25 12-32 9-7 21-11 36-11h1v19h-2zm75 34c19 0 35 6 47 20 12 12 18 28 18 48 0 19-6 36-18 48a61 61 0 01-47 20c-19 0-35-7-47-20a69 69 0 01-18-48c0-20 6-36 18-48 12-14 28-20 47-20zm0 118c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm156-118v20h-2c-14 0-25 5-34 17-9 11-13 24-13 39v58h-19V87h19v32c4-13 13-23 27-30 6-3 13-4 21-4h1zM1617 293v175h-19v-78h-101v78h-19V293h19v78h101v-78h19zm91 159c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c1 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm187 95a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-36 18-49 11-13 27-19 47-19 19 0 34 7 45 23v-21h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm114 16h-19V283h19v185zm46 0V353h-27v-17h27v-48h19v48h30v17h-30v115h-19zm87-185v73l17-16c7-4 15-6 24-6 8 0 16 1 22 3a58 58 0 0133 54v77h-20v-77c0-12-3-21-10-29-7-7-16-10-26-10a39 39 0 00-40 40v76h-19V283h19zm280 164a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm109-116v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 11 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10a39 39 0 00-39 40v76h-19V336h19zm222 111a52 52 0 01-47 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-74h19v185h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm233-1a56 56 0 0053-36h21c-6 17-15 30-28 39a82 82 0 01-50 16c-25 0-46-9-61-26a92 92 0 01-22-64c0-25 7-46 22-63 15-18 36-26 61-26a78 78 0 0178 54h-21c-4-11-11-19-20-25-10-7-20-10-33-10-12 0-22 2-30 5-9 4-15 9-21 15a73 73 0 00-17 50c0 21 6 37 17 50 12 14 29 21 51 21zm198-4a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 48-19 19 0 34 7 45 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm163-118v19h-2c-14 0-26 6-34 18-9 10-13 23-13 39v58h-19V336h19v32c4-14 13-24 27-30 6-3 13-4 21-4h1zm73 118c18 0 31-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-19 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 18-49s27-19 47-19c19 0 35 6 47 19s17 29 17 49v8h-109c2 12 7 22 15 30s19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm162-40v59h96v19h-96v59h108v19h-127V293h127v19h-108zm189 88l51 68h-25l-37-54-37 54h-25l51-68-48-64h25l34 50 33-50h25l-47 64zm120 52c9 0 16-3 23-7 6-5 11-11 14-19h21c-4 13-12 24-22 32-11 8-24 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19a60 60 0 0161 44h-20c-3-8-8-15-14-19-7-5-14-7-23-7-8 0-15 1-21 4-6 2-10 6-14 10-9 10-13 22-13 36s4 26 13 35c8 10 20 15 35 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-20 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 13-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm105 116h-19V283h19v185zm51 0h-20V283h20v185zm89-16c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c2 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm105-16v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 12 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10s-20 3-28 11c-7 7-11 17-11 29v76h-19V336h19zm185 116a40 40 0 0037-26h21c-4 13-12 24-22 32-11 8-25 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19c15 0 29 4 40 12 10 8 18 18 22 31h-21c-3-7-8-14-15-18-6-5-13-7-22-7-8 0-15 1-21 4-6 2-11 6-15 10-8 10-12 22-12 36s4 26 12 35c9 10 21 15 36 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 18 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-15 28h89c-2-11-6-21-14-28-8-8-18-11-30-11zM412 454c0 16-7 19-18 19h-53c-11 0-20-4-27-13L130 213h-2v242c0 13-6 18-18 18H52c-14 0-20-3-20-18V62c0-16 7-19 20-19h52c13 0 19 3 26 13l184 248h1V61c0-14 7-18 19-18h60c16 0 17 8 17 19v392h1zm197 4c0 7-5 14-14 14h-71c-9 0-14-7-14-14V56c0-8 5-15 14-15h71c9 0 14 7 14 14v403zm415-380l-18 52c-2 6-5 9-9 9l-8-2c-33-16-58-21-87-21-65 0-106 49-106 140 0 98 47 140 107 140 29 0 55-5 84-17l9-3c6 0 9 3 11 10l16 46 2 10c0 6-3 11-12 14-42 16-77 24-125 24-131 0-197-87-197-221S772 32 896 32c45 0 82 9 118 25 9 4 12 8 12 12l-2 9zm336-37c13 0 17 6 16 15l-6 50c-1 13-9 15-24 15h-149v93h140c14 0 19 7 19 17v45c0 12-7 18-18 18h-141v98h161c11 0 18 5 18 17v46c0 11-6 17-17 17h-240c-14 0-21-4-21-19V59c0-11 6-18 16-18h246z" fill="currentColor"></path></svg></a><div class="Header-module--wrapper--2e13D"><div class="Header-module--search--2nfnz"><form id="global-nav-search-form" role="search" action="https://cks.nice.org.uk/search" class="Search-module--search--2wNll"><label class="Search-module--label--1rrog" for="autocomplete">Search CKS…</label><div class="Autocomplete-module--ac--2PqiF"><div class="autocomplete__wrapper"><input type="search" id="autocomplete" name="q" class="autocomplete__input autocomplete__input--default" placeholder="Search CKS…" data-hj-allow="" maxLength="512" value=""/></div></div><button class="Search-module--button--2FbnI" type="submit" aria-label="Perform search"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="Search-module--icon--2JB42" aria-hidden="true" focusable="false"><path d="M83.784 476.472L197.112 363.16c30.144 20.32 65.056 30.528 100.032 30.528 45.904 0 91.776-17.488 126.8-52.528 70.064-70.064 70.064-183.584 0-253.616C388.936 52.504 343.048 35 297.144 35c-45.904 0-91.808 17.504-126.848 52.528-61.696 61.696-68.976 157.12-21.968 226.864L35 427.752l48.784 48.72zm213.36-137.952c-33.168 0-64.352-12.896-87.792-36.368-48.416-48.448-48.416-127.2 0-175.616 23.44-23.44 54.64-36.352 87.792-36.352s64.336 12.912 87.776 36.368c23.44 23.456 36.384 54.64 36.384 87.792s-12.928 64.352-36.384 87.792c-23.456 23.472-54.624 36.368-87.776 36.368v.016z" fill="currentColor"></path></svg></button></form></div><button class="Header-module--mobileMenuBtn--1LgyL" id="header-menu-button" type="button" aria-controls="header-menu" aria-expanded="false" aria-haspopup="menu" aria-label="Expand site menu">Menu</button></div></div><div id="header-menu" class="Nav-module--wrapper--2_xng Nav-module--wrapperWithSubLinks--3PUfX"><nav class="Nav-module--nav--2aQpa" aria-label="primary navigation"><div class="Nav-module--menuWrapper--2fp8S"><ul class="Nav-module--menuList--264L-" aria-labelledby="header-menu-button"><li><a href="https://pathways.nice.org.uk/" class="Nav-module--link--3JzDA">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Nav-module--link--3JzDA">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Nav-module--link--3JzDA">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Nav-module--link--3JzDA">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary">BNF<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Nav-module--link--3JzDA"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">Clinical Knowledge Summaries</span></a><div class="SubNav-module--wrapper--yAXWY"><ul class="SubNav-module--list--1K9bK" aria-label="CKS links"><li class="SubNav-module--imageLink--3xwIS"><a href="../../../../index.html" class="SubNav-module--link--39i23" aria-label="CKS - Home"><img src="data:image/svg+xml;base64,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" class="SubNav-module--image--uq-a2" alt=""/></a></li><li><a href="../../../index.html" class="SubNav-module--link--39i23" aria-label="Health topics A to Z">Health topics A to Z</a></li><li><a href="../../../../specialities/index.html" class="SubNav-module--link--39i23" aria-label="Specialities">Specialities</a></li><li><a href="../../../../whats-new/index.html" class="SubNav-module--link--39i23" aria-label="What&#x27;s new">What&#x27;s new</a></li><li><a href="../../../../about/index.html" class="SubNav-module--link--39i23" aria-label="About CKS">About CKS</a></li></ul></div></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Nav-module--link--3JzDA">Journals and databases</a></li></ul></div></nav></div></header><aside class="CoronaMessage-module--wrapper--zRiaV" aria-label="COVID-19 Notice"><div class="CoronaMessage-module--container--36Biz"><p>Read about<!-- --> <a href="https://www.nice.org.uk/covid-19">our approach to COVID-19</a></p></div></aside></div></div><main class="Layout-module--main--1OIFf" id="content-start"><div class="container"><nav aria-label="Breadcrumbs" role="navigation"><ol class="breadcrumbs"><li class="breadcrumbs__crumb"><a href="https://www.nice.org.uk/">NICE</a></li><li class="breadcrumbs__crumb"><a href="../../../../index.html">CKS</a></li><li class="breadcrumbs__crumb"><a href="../../../index.html">Health topics A to Z</a></li><li class="breadcrumbs__crumb"><a href="../../index.html">Depression - antenatal and postnatal</a></li><li class="breadcrumbs__crumb"><a href="../index.html">Management</a></li><li class="breadcrumbs__crumb"><span>Scenario: Pregnant: on an antidepressant</span></li></ol></nav><script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://www.nice.org.uk/","name":"NICE"}},{"@type":"ListItem","position":2,"item":{"@id":"/","name":"CKS"}},{"@type":"ListItem","position":3,"item":{"@id":"/topics/","name":"Health topics A to Z"}},{"@type":"ListItem","position":4,"item":{"@id":"/topics/depression-antenatal-postnatal/","name":"Depression - antenatal and postnatal"}},{"@type":"ListItem","position":5,"item":{"@id":"/topics/depression-antenatal-postnatal/management/","name":"Management"}},{"@type":"ListItem","position":6,"item":{"name":"Scenario: Pregnant: on an antidepressant"}}]}</script><div class="page-header"><h1 class="page-header__heading"><span class="page-header__pre-heading">Depression - antenatal and postnatal: </span><span>Scenario: Pregnant woman: on an antidepressant</span></h1><p class="page-header__lead"><span>Last revised in August 2020</span></p></div><p class="visually-hidden">Covers the management of a woman being treated for depression who becomes pregnant.</p><div class="ChapterContents-module--wrapper--3ONbu"><div class="ChapterContents-module--menu--3Epka"><nav class="stacked-nav" aria-label="Depression - antenatal and postnatal chapters"><ul class="stacked-nav__list"><li class="stacked-nav__list-item" data-tracking="Summary"><a aria-current="false" href="../../index.html"><span class="stacked-nav__content-wrapper">Summary</span></a></li><li class="stacked-nav__list-item" data-tracking="Have I got the right topic?"><a aria-current="false" href="../../have-i-got-the-right-topic/index.html"><span class="stacked-nav__content-wrapper">Have I got the right topic?</span></a></li><li class="stacked-nav__list-item" data-tracking="How up-to-date is this topic?"><a aria-current="false" href="../../how-up-to-date-is-this-topic/index.html"><span class="stacked-nav__content-wrapper">How up-to-date is this topic?</span></a></li><li class="stacked-nav__list-item" data-tracking="Goals and outcome measures"><a aria-current="false" href="../../goals-outcome-measures/index.html"><span class="stacked-nav__content-wrapper">Goals and outcome measures</span></a></li><li class="stacked-nav__list-item" data-tracking="Background information"><a aria-current="false" href="../../background-information/index.html"><span class="stacked-nav__content-wrapper">Background information</span></a></li><li class="stacked-nav__list-item" data-tracking="Diagnosis"><a aria-current="false" href="../../diagnosis/index.html"><span class="stacked-nav__content-wrapper">Diagnosis</span></a></li><li class="stacked-nav__list-item" data-tracking="Management"><a aria-current="false" href="../index.html"><span class="stacked-nav__content-wrapper">Management</span></a><ul class="stacked-nav__nested"><li class="stacked-nav__list-item" data-tracking="Management | Scenario: Pregnant: on an antidepressant"><a aria-current="true" class="" href="index.html"><span class="stacked-nav__content-wrapper">Scenario: Pregnant: on an antidepressant</span></a></li><li class="stacked-nav__list-item" data-tracking="Management | Scenario: Pregnant: new episode"><a aria-current="false" href="../pregnant-new-episode/index.html"><span class="stacked-nav__content-wrapper">Scenario: Pregnant: new episode</span></a></li><li class="stacked-nav__list-item" data-tracking="Management | Scenario: Postnatal: new episode"><a aria-current="false" href="../postnatal-new-episode/index.html"><span class="stacked-nav__content-wrapper">Scenario: Postnatal: new episode</span></a></li></ul></li><li class="stacked-nav__list-item" data-tracking="Prescribing information"><a aria-current="false" href="../../prescribing-information/index.html"><span class="stacked-nav__content-wrapper">Prescribing information</span></a></li><li class="stacked-nav__list-item" data-tracking="Supporting evidence"><a aria-current="false" href="../../supporting-evidence/index.html"><span class="stacked-nav__content-wrapper">Supporting evidence</span></a></li><li class="stacked-nav__list-item" data-tracking="How this topic was developed"><a aria-current="false" href="../../how-this-topic-was-developed/index.html"><span class="stacked-nav__content-wrapper">How this topic was developed</span></a></li><li class="stacked-nav__list-item" data-tracking="References"><a aria-current="false" href="../../references/index.html"><span class="stacked-nav__content-wrapper">References</span></a></li></ul></nav></div><div class="ChapterContents-module--onThisPage--1333P"><nav class="ChapterOnThisPage-module--wrapper--2zc7n" aria-labelledby="on-this-page"><h2 class="ChapterOnThisPage-module--heading--2SdDN" id="on-this-page">On this page</h2><ol class="ChapterOnThisPage-module--rootList--2II70" aria-label="Jump links to section on this page"><li><a href="index.html#making-decisions-about-treatment">Making decisions about treatment</a><ol aria-label="Sections within Making decisions about treatment" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-6d5">Basis for recommendation</a></li></ol></li><li><a href="index.html#managing-a-woman-on-treatment-who-becomes-pregnant">Managing a woman on treatment who becomes pregnant</a><ol aria-label="Sections within Managing a woman on treatment who becomes pregnant" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-c04">Basis for recommendation</a></li></ol></li><li><a href="index.html#referral-specialist-advice">Referral and specialist advice</a><ol aria-label="Sections within Referral and specialist advice" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-b24">Basis for recommendation</a></li></ol></li><li><a href="index.html#prescribing-antidepressants-in-pregnancy">Prescribing antidepressants in pregnancy</a><ol aria-label="Sections within Prescribing antidepressants in pregnancy" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-7dc">Basis for recommendation</a></li></ol></li><li><a href="index.html#follow-up">Follow up</a><ol aria-label="Sections within Follow up" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-b00">Basis for recommendation</a></li></ol></li></ol></nav></div><div class="ChapterContents-module--body--1XBoo"><section aria-labelledby="pregnant-on-an-antidepressant" class="ChapterBody-module--wrapper--2HCfk "><h2 id="pregnant-on-an-antidepressant" class="visually-hidden">Scenario: Pregnant woman: on an antidepressant</h2><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 32d0d493-20cc-4d53-b64b-86065e226bc3 --><!-- begin field 33b2492f-8b72-4457-a848-acd900abecd4 --><p>From age 18 years to 60 years (Female).</p><!-- end field 33b2492f-8b72-4457-a848-acd900abecd4 --><!-- end item 32d0d493-20cc-4d53-b64b-86065e226bc3 --></div><section aria-labelledby="making-decisions-about-treatment" class="ChapterBody-module--wrapper--2HCfk "><h3 id="making-decisions-about-treatment">What issues should I consider when making decisions about treatment?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 3317ca64-84bb-4d3a-b916-49d287e0f33b --><!-- begin field d588b882-3cfd-45ad-8d18-5aaaa67a3a53 --><p><strong>B</strong><strong><strong>e</strong>fore discussing the benefits and harms of treatment, or starting, stopping or switching antidepressant treatment during pregnancy, seek advice, ideally from a specialist perinatal mental health team, where available; or from a secondary mental health service; or the UK Teratology Information Service (UKTIS) on </strong><strong>0344 892 0909.</strong><strong> </strong></p><ul><li><strong>Decisions about treating depression during pregnancy should be made on an individual basis.</strong> Involve the woman, and her family where appropriate, in <em>all </em>decisions about treatment, taking into account information on:<ul><li>The nature of her depression and severity of symptoms.</li><li>Any psychiatric and physical comorbidities.</li><li>Previous history and response to treatment.</li><li>Stage of pregnancy.</li><li>The options available and their risk, harms and benefits. </li><li>The woman's relationships with, and level of support from, family or carers and the needs of her family (for example the welfare of her baby and other children). </li></ul></li><li><strong>Discuss: </strong><ul><li>Any particular concerns the woman has about her baby.</li><li>Her plans regarding breastfeeding. Explain the benefits of breastfeeding and the risks associated with taking psychotropic medication when breastfeeding.</li><li>The risks or harms to the woman or fetus of stopping antidepressants abruptly or changing treatment. </li><li>The risks associated with <em>not </em>treating depression during pregnancy.  </li><li>The risks associated with any pregnancy:<ul><li>Miscarriage or birth defect can occur in any pregnancy even if medication has not been taken.</li><li>The risk of miscarriage in pregnancy is about 10 to 20 out of every 100 pregnancies.</li><li>The risk of birth defect is about 1 in 40 pregnancies.</li></ul></li><li>The treatment options available to the woman (including psychological treatment, antidepressant treatment, or a combination of psychological and antidepressant treatment), including: <ul><li>The higher threshold for pharmacological interventions arising from the changing risk-benefit ratio for psychotropic medication at this time (also note that no psychotropic medication has a UK marketing authorisation specifically for women who are pregnant or breastfeeding) and the likely benefits of a psychological intervention. </li><li>The potential benefits of each treatment, considering the severity of the mental health problem.</li><li>The risks or harms to the woman and the fetus associated with each treatment option. Discuss the uncertainty about whether any increased risk to the fetus and other problems for the woman or baby can be attributed directly to these drugs or may be caused by other factors.</li><li>Treatment options that would enable a woman to breastfeed if she wishes.</li><li>The uncertainty about the benefits, risks and harms of treatments for mental health problems in pregnancy.</li><li>The need for prompt treatment because of the potential effect of an untreated mental health problem on the fetus.</li></ul></li></ul></li><li>For more specific management information, see <a class="topic-reference internal-reference" href="index.html#managing-a-woman-on-treatment-who-becomes-pregnant">Managing a woman on treatment who becomes pregnant</a>.</li></ul><!-- end field d588b882-3cfd-45ad-8d18-5aaaa67a3a53 --><!-- end item 3317ca64-84bb-4d3a-b916-49d287e0f33b --></div><section aria-labelledby="basis-for-recommendation-6d5" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-6d5">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 6d594605-a1a3-4893-946a-b7d7d2a8749e --><!-- begin field 398203f9-4119-4764-96ad-ddd2f1bda5dc --><h5>Seeking specialist advice</h5><ul><li>This recommendation is extrapolated from the opinion of the National Institute for Health and Care Excellence (NICE) that advises considering seeking advice, preferably from a specialist perinatal mental health service, when more detailed advice about risks of mental health problems or the benefits and harms of treatment in pregnancy is needed, or when psychotropic medication is started in pregnancy [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. It is also extrapolated from an evidence review commissioned by NICE that noted that considerable caution should be used when changing or stopping antidepressant drugs in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>].</li><li>Seeking specialist advice is also recommended due to the uncertainty regarding the benefits, risks and potential harms of mental health treatments in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>], the fact that the UK Teratology Information Service (UKTIS) does not make specific recommendations on the 'safest' antidepressants in pregnancy, the fact that there are no antidepressants licensed for use during pregnancy (although the use of antidepressants during pregnancy is common) [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>] and the opinion of the NICE guideline development group that specialist knowledge is required when assessing the trade-off of the benefits and harms of psychotropic medication for mental health problems in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>].</li></ul><h5>Decision making</h5><ul><li>This recommendation is based on the NICE <em>Antenatal and postnatal mental health: clinical management and service guideline </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]<strong> </strong>and the expert opinion of the NICE guideline development group, which advocated women being actively involved in decisions about their care [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. The list of information to take into account also includes advice from a British Association for Psychopharmacology consensus guidance [<a class="bibliography-reference internal-reference" href="../../references/index.html">McAllister-Williams et al, 2017</a>] and Canadian best practice guidelines for mental health disorders in the perinatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">BC Reproductive Mental Health Program, 2014</a>]. </li></ul><h5>Areas for discussion</h5><ul><li>This recommendation largely reflects the NICE <em>Antenatal and postnatal mental health: clinical management and service guideline,</em> including the treatment options available to women and specific discussion points associated with them [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. The National Collaborating Centre for Mental Health states that, for women with depression in pregnancy or the postnatal period, there should be a discussion about treatment options, including benefits and harms, and the potential consequences of abruptly stopping or changing drug treatment [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. <ul><li><strong>The woman's preferences regarding breastfeeding</strong> — women being prescribed an antidepressant in pregnancy are likely to need to continue treatment in the postpartum period as well. Therefore, it seems sensible to consider the woman's desire to breastfeed at this stage, to avoid the need to consider switching antidepressants later [<a class="bibliography-reference internal-reference" href="../../references/index.html">SIGN, 2012</a>].  </li><li><strong>Risks of abrupt withdrawal of antidepressants </strong>— the Scottish Intercollegiate Guidelines Network (SIGN) advises that abrupt discontinuation of antidepressant treatment in women with serious mental illness who are at high risk of relapse is unwise, as relapse may ultimately be more harmful to the mother and child than continued drug treatment [<a class="bibliography-reference internal-reference" href="../../references/index.html">SIGN, 2012</a>]. NICE also emphasises the importance of not stopping medication without professional advice because of the risk of triggering or exacerbating an episode [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2016</a>]. This is consistent with advice from a British Association for Psychopharmacology consensus guidance which discusses avoidance of suddenly stopping antidepressants on discovering a pregnancy because of the risk of discontinuation syndrome and relapse. Suddenly stopping medication when a woman finds out she is pregnant may not remove the risk of malformations [<a class="bibliography-reference internal-reference" href="../../references/index.html">McAllister-Williams et al, 2017</a>].  </li><li><strong>Risks of not treating depression</strong> — there is some evidence to suggest an increased risk of adverse outcomes for women with severe depression and their babies, including low birthweight, prematurity, sudden infant death syndrome, and self harm [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. <strong> </strong></li><li><strong>Risks associated with any pregnancy</strong> — the information about the background risk of fetal malformations for pregnant women without a mental disorder is based on information from the UK Teratology Information Service [<a class="bibliography-reference internal-reference" href="../../references/index.html">UKTIS, 2013</a>]. </li></ul></li></ul><!-- end field 398203f9-4119-4764-96ad-ddd2f1bda5dc --><!-- end item 6d594605-a1a3-4893-946a-b7d7d2a8749e --></div></section></section><section aria-labelledby="managing-a-woman-on-treatment-who-becomes-pregnant" class="ChapterBody-module--wrapper--2HCfk "><h3 id="managing-a-woman-on-treatment-who-becomes-pregnant">How should I manage a woman being treated for depression who becomes pregnant?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 0180623c-c015-4a33-9f3d-a76f00bd9c5f --><!-- begin field c31b7e42-83e1-4441-8348-a76f00bd9e54 --><p><strong>Before discussing the benefits and harms of treatment, or starting, stopping or switching antidepressant treatment during pregnancy, seek advice, ideally from a specialist perinatal mental health team, where available; or from a secondary mental health service; or the UK Teratology Information Service (UKTIS) on 0344 892 0909. For more information on prescribing antidepressants and their risks in pregnancy,</strong> see <a class="topic-reference internal-reference" href="index.html#prescribing-antidepressants-in-pregnancy">Prescribing antidepressants in pregnancy</a>.</p><ul><li><strong>Advise the woman not to stop taking antidepressants abruptly during pregnancy.</strong></li><li><strong>If a woman taking a tricyclic antidepressant (TCA), selective serotonin reuptake inhibitor (SSRI), or a (serotonin-) noradrenaline reuptake inhibitor [(S)NRI] for mild to moderate depression becomes pregnant:</strong><ul><li>Discuss gradually stopping the antidepressant and monitoring the woman. </li><li>Consider referral for facilitated self-help. </li></ul></li><li><strong>If the woman is taking a TCA, SSRI, or (S)NRI for moderate depression and wants to stop her medication,</strong> consider her previous response to treatment, stage of pregnancy, preferences for treatment, risk of relapse, and risks of medication and discuss the options of:<ul><li>Switching to a high intensity psychological intervention (for example CBT).</li><li>Changing medication if there is a drug effective for her with a lower risk of adverse effects.</li></ul></li><li><strong>If the woman is taking a TCA, SSRI, or (S)NRI for severe depression,</strong> take into account her previous response to treatment, stage of pregnancy, preferences for treatment, risk of relapse, and risks of medication and discuss the options of: <ul><li>Continuing her current medication.</li><li>Switching to a drug that is effective for her with a lower risk of adverse effects.</li><li>Using medication in conjunction with a high-intensity psychological intervention (for example CBT).</li><li>Switching to a high-intensity psychological intervention (for example CBT) if she decides to stop taking medication</li></ul></li><li><strong>If the woman requires psychological treatment,</strong> ensure that she is assessed within 2 weeks of referral and is seen promptly for treatment (ideally, within 1 month of initial assessment). </li><li><strong>If a woman with depression decides to stop taking psychotropic medication in pregnancy and the postnatal period,</strong> monitor her mental status because of the risk of relapse. Discuss with her:<ul><li>Her reasons for stopping.</li><li>The possibility of other options: for example having a psychological intervention, restarting medication if the depression is or has been severe and there has been a previous good response to treatment, or switching to other medication.</li><li>Increasing her monitoring and support while she is not taking any medication.</li><li>Any risks to herself, or the fetus or baby when stopping medication.</li></ul></li><li><strong>Offer written information,</strong> for example, the Mind publication <a data-hyperlink-id="b69fb058-541c-472e-b8b8-a98c016a64db" href="https://www.mind.org.uk/media/4852718/understanding-postnatal-depression-2016.pdf">Understanding postnatal depression and perinatal mental health</a>, available at <a data-hyperlink-id="7d73aad8-c403-476a-b2e7-a98c016a64f5" href="https://www.mind.org.uk/">www.mind.org.uk</a>.</li></ul><!-- end field c31b7e42-83e1-4441-8348-a76f00bd9e54 --><!-- end item 0180623c-c015-4a33-9f3d-a76f00bd9c5f --></div><section aria-labelledby="basis-for-recommendation-c04" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-c04">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item c04e4833-c371-4c66-80d7-a76f00bd9e54 --><!-- begin field 87287318-294a-43cf-b3a6-a76f00bd9e54 --><p>The recommendations on management of a woman taking an antidepressant who becomes pregnant are largely based on the National Institute for Health and Care Excellence (NICE) publication <em>Antenatal and postnatal mental health: clinical management and service guidance </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>].</p><h5>Seeking specialist advice on antidepressant treatment</h5><ul><li>This recommendation is extrapolated from the opinion of NICE that advises considering seeking advice, preferably from a specialist perinatal mental health service, when more detailed advice about risks of mental health problems or the benefits and harms of treatment in pregnancy is needed, or when psychotropic medication is started in pregnancy [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. It is also extrapolated from an evidence review commissioned by NICE that noted that considerable caution should be used when changing or stopping antidepressant drugs in pregnancy [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>].</li><li>Seeking specialist advice is also recommended due to the uncertainty regarding the benefits, risks and potential harms of mental health treatments in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>], the fact that the UK Teratology Information Service (UKTIS) does not make specific recommendations on the 'safest' antidepressants in pregnancy, the fact that there are no antidepressants licensed for use during pregnancy (although the use of antidepressants during pregnancy is common), and the opinion of the NICE guideline development group that specialist knowledge is required when assessing the trade-off of the benefits and harms of psychotropic medication for mental health problems in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>].</li></ul><h5>Abrupt withdrawal of antidepressants</h5><ul><li>The Scottish Intercollegiate Guidelines Network (SIGN) advises that abrupt discontinuation of antidepressant treatment in women with serious mental illness who are at high risk of relapse is unwise, as relapse may ultimately be more harmful to the mother and child than continued drug treatment [<a class="bibliography-reference internal-reference" href="../../references/index.html">SIGN, 2012</a>]. NICE also emphasises the importance of not stopping medication without professional advice because of the risk of triggering or exacerbating an episode [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2016</a>]. This is consistent with advice from a British Association for Psychopharmacology consensus guidance which advises avoidance of suddenly stopping antidepressants on discovering a pregnancy because of the risk of discontinuation syndrome and relapse [<a class="bibliography-reference internal-reference" href="../../references/index.html">McAllister-Williams et al, 2017</a>]. </li></ul><h5>Treating depression in pregnancy</h5><ul><li>The recommendations to manage pre-existing depression in pregnancy depending on its severity are based mainly on the NICE publication <em>Antenatal and postnatal mental health: clinical management and service guidance </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. </li><li>Where possible, non-pharmacological management of depression is preferable in pregnancy, particularly in women with mild to moderate symptoms [<a class="bibliography-reference internal-reference" href="../../references/index.html">BC Reproductive Mental Health Program, 2014</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">UKTIS, 2017</a>]. </li><li>NICE recommends discussing stopping antidepressants gradually in women with mild to moderate depression who become pregnant [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. However relapse rates are high in people with a history of depression who discontinue their treatment, and not treating depression in pregnancy may be associated with adverse outcomes for the woman, her pregnancy, and her infant [<a class="bibliography-reference internal-reference" href="../../references/index.html">SIGN, 2012</a>]. </li></ul><h5>Efficacy of non-pharmacological treatment in pregnancy and the postnatal period</h5><ul><li>There are few studies of the efficacy of psychological treatments in pregnant women. Given that the nature of most mental health problems during pregnancy is similar to that in non-pregnant women, it seems reasonable to assume that these psychological treatments are also likely to be effective in pregnant women [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li><li>When making its recommendations for women with varying severities of depression in pregnancy and the postnatal period, the NICE guideline development group (GDG) considered the evidence for the clinical and cost-effectiveness of facilitated self help and structured psychological interventions for the treatment of depression in non-pregnant women and also took into account the findings of an evidence review [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]:  <ul><li>Up to three studies (n = 1136) showed moderate clinical benefits of facilitated self help on the symptoms of depression compared with usual treatment in women with subthreshold to moderate symptoms of depression in pregnancy or the postnatal period (very low to high quality evidence).</li><li>Up to ten studies showed large to moderate benefits with structured psychological interventions (CBT or IPT) in terms of depression diagnosis and symptoms (very low to high quality evidence), in addition to continued moderate to large effects in the short and intermediate term (low quality evidence).</li><li>One study showed a large effect of structured psychological interventions on anxiety symptoms in women with depression (low quality evidence).</li></ul></li><li>For persistent subthreshold depressive symptoms, or mild to moderate depression, the GDG recommended considering facilitated self help and that its delivery should include written materials, support by a trained practitioner face-to-face or by telephone, and take place in usually six to eight sessions over a nine to twelve week period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li><li>For moderate to severe depression in pregnancy or the postnatal period, the GDG advised offering options in line with existing NICE guidance (taking into account the higher threshold for pharmcological treatment in pregnancy or breastfeeding), including structured psychological interventions (CBT or IPT) [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li></ul><h5>Efficacy of pharmacological treatments in pregnancy and the postnatal period</h5><ul><li>There is good evidence of efficacy for pharmacological treatments for depression in the general population (see the NICE guideline <em>Depression: the treatment and management of depression in adults</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2009</a>] for more information). Because of ethical considerations, there are few data regarding the efficacy of antidepressants in pregnant women [<a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2012</a>]; however, pharmacological treatments are not thought to have any differential benefit in pregnancy or the postnatal period compared with their use in other adult populations. The main difference at this time is the risk-benefit ratio [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li><li>An evidence review on the efficacy of pharmacological interventions for mental health problems in pregnancy and the postnatal period commissioned by NICE found [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]: <ul><li>One small study (n = 31) showing a moderate beneficial effect of mean depression scores when paroxetine was compared with placebo (very low quality evidence).</li><li>Another study (n = 83) that found SSRIs had no statistically significant benefit compared with TCAs in terms of mean depression scores either post-treatment or at intermediate follow up (low quality evidence).</li><li>Three studies (n = 188) indicating SSRIs combined with psychosocial interventions had a moderately beneficial effect on mean depression scores post intervention compared with placebo plus psychological interventions (low quality evidence).</li><li>One study (n = 254) showing a moderate beneficial effect of antidepressants compared with general supportive care in terms of symptoms of depression post-treatment (very low quality evidence).</li></ul></li></ul><h5>Prompt treatment for women requiring psychological treatment</h5><ul><li>The recommendation that psychological interventions for a pregnant or postnatal woman with a mental health problem should be provided within 1 month of initial assessment is based on <em>Antenatal and postnatal mental health: clinical management and service guidance, </em>published by NICE [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. The Royal College of Psychiatrists also note that psychological therapy services (including Improving Access to Psychological Therapies [IAPT]) should ensure prompt assessment and treatment of perinatal women [<a class="bibliography-reference internal-reference" href="../../references/index.html">Royal College of Psychiatrists, 2015</a>].  </li><li>Reasons for the need for prompt intervention include [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2016</a>]: <ul><li>The potential impact of the woman's depression on the fetus or baby and her ability to function and care for herself and others in her family.</li><li>Prioritisation of psychological interventions because of the higher threshold for drug treatments in pregnancy, taking into account the altered risk-benefit ratio at this time. </li></ul></li><li>However, it is acknowledged that access to psychological treatments may be limited, creating challenges for perinatal services [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li></ul><h5>Stopping psychotropic medication in pregnancy and the postnatal period</h5><ul><li>This recommendation is based on <em>Antenatal and postnatal mental health: clinical management and service guidance, </em>published by NICE [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]<strong> </strong>and Canadian best practice guidelines on mental health disorders in the perinatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">BC Reproductive Mental Health Program, 2014</a>]. </li></ul><h5>Offering written information</h5><ul><li>CKS has based this recommendation on the NICE recommendation to provide culturally relevant information on mental health problems in pregnancy and the postnatal period to the woman [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. </li></ul><!-- end field 87287318-294a-43cf-b3a6-a76f00bd9e54 --><!-- end item c04e4833-c371-4c66-80d7-a76f00bd9e54 --></div></section></section><section aria-labelledby="referral-specialist-advice" class="ChapterBody-module--wrapper--2HCfk "><h3 id="referral-specialist-advice">When should I refer or seek specialist advice?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item d6bd260b-be13-49f3-b745-a76f00c0775b --><!-- begin field c6d107f6-8b35-4ecf-bab5-a76f00c07916 --><ul><li><strong>Urgently refer to a secondary mental health team (ideally with a special interest in perinatal mental health)</strong> if a woman:<ul><li>Is severely depressed and presents a considerable immediate risk of harm to herself or other people — admission may be required if clinically indicated. </li><li>Shows evidence of severe self-neglect or is unable to care for her infant.</li><li>Has a possible diagnosis of bipolar disorder. For more information, see the CKS topic on <a class="topic-reference external-reference" href="../../../bipolar-disorder/index.html">Bipolar disorder</a>.</li><li>Has a history of severe mental illness, including postnatal depression, puerperal psychosis, or bipolar disorder (during pregnancy or the postnatal period or at any other time). </li></ul></li><li><strong>Refer to a specialist substance misuse service</strong> if, in addition to depression, the woman has harmful or dependent drug or alcohol misuse in pregnancy or the postnatal period.</li><li><strong>Refer or seek specialist advice if:</strong><ul><li>Considering continuing, starting, stopping, or switching antidepressant treatment during pregnancy.</li><li>Considering reducing the dose of, or discontinuing, antidepressant treatment close to delivery.</li><li>The woman is not responding to treatment appropriate to the severity of her depression.<ul><li>Specialist advice may be sought ideally from a specialist perinatal mental health team where available, or from a secondary mental health service or the UK Teratology Information Service (UKTIS) on 0844 892 0909.</li></ul></li></ul></li><li><strong>Other factors to be taken into account when deciding whether to refer or seek specialist advice include:</strong><ul><li>The woman's preference.</li><li>The woman's past history and response to treatment.</li><li>The degree of functional impairment.</li><li>The presence of significant comorbidities or specific symptoms.</li></ul></li></ul><!-- end field c6d107f6-8b35-4ecf-bab5-a76f00c07916 --><!-- end item d6bd260b-be13-49f3-b745-a76f00c0775b --></div><section aria-labelledby="basis-for-recommendation-b24" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-b24">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item b2466a7a-970c-47a5-a3a7-a76f00c0791b --><!-- begin field ef4d78fb-7434-4732-8739-a76f00c0791b --><h5>Urgent referral </h5><ul><li>These recommendations reflect referral advice in the NICE publication <em>Antenatal and postnatal mental health: clinical management and service guidance </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. Recommendations have also been extrapolated from the NICE guidance <em>Depression in adults: recognition and management</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2009</a>] (although this is not specifically aimed at women in the antenatal or postnatal period). CKS has recommended the same diagnostic criteria for depression in the antenatal and postnatal periods, based on advice from the National Collaborating Centre for Mental Health to use usual diagnostic guidelines [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. It would seem reasonable therefore to extrapolate referral advice to cover women who are depressed either antenatally or postnatally.</li><li>Urgent referral criteria also reflect expert opinion in clinical practice articles [<a class="bibliography-reference internal-reference" href="../../references/index.html">Langan and Goodbred, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Stewart and Vigod, 2016</a>].  </li></ul><h5>Referral to a specialist substance misuse service</h5><ul><li>This recommendation is based on the NICE publication <em>Antenatal and postnatal mental health: clinical management and service guidance </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. </li></ul><h5>Referral or seeking advice on treatment decisions</h5><ul><li>This recommendation on antidepressant treatment during pregnancy is extrapolated from the opinion of NICE that advises considering seeking advice, preferably from a specialist perinatal mental health service, when psychotropic medication is started in pregnancy [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. It is also extrapolated from an evidence review commissioned by NICE that noted that considerable caution should be used when changing or stopping antidepressant drugs in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li><li>Seeking specialist advice is also recommended due to the uncertainty regarding the benefits, risks, and potential harms of mental health treatments in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>], the fact that the UK Teratology Information Service (UKTIS) does not make specific recommendations on the 'safest' antidepressants in pregnancy, and the opinion of the NICE guideline development group that specialist knowledge is required when assessing the trade-off of the benefits and harms of psychotropic medication for mental health problems in pregnancy or the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>].</li><li>There is a lack of evidence or expert consensus regarding whether the risk of poor neonatal adaptation will be influenced by reducing or stopping antidepressant treatment close to delivery and it may increase the woman's risk of relapse and postnatal depression [<a class="bibliography-reference internal-reference" href="../../references/index.html">McAllister-Williams et al, 2017</a>]. </li><li>NICE recommends treating depression according to the severity of the episode [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. If the treatment recommended by NICE for the severity of the woman's depression is not controlling symptoms, CKS recommends seeking specialist advice. </li></ul><h5>Factors influencing the decision to refer</h5><ul><li>NICE advocates discussion with the woman about the risks and benefits of interventions, and her values and preferences in order for her to reach a fully informed decision and suggests also involving (with the woman's agreement) her partner, family or carer, in decision making [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. Other factors are based on what CKS considers to be good clinical practice. </li></ul><!-- end field ef4d78fb-7434-4732-8739-a76f00c0791b --><!-- end item b2466a7a-970c-47a5-a3a7-a76f00c0791b --></div></section></section><section aria-labelledby="prescribing-antidepressants-in-pregnancy" class="ChapterBody-module--wrapper--2HCfk "><h3 id="prescribing-antidepressants-in-pregnancy">What should I consider before prescribing an antidepressant in pregnancy?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 41b1f2e7-0932-455f-93b0-a76f00c31ecf --><!-- begin field b90609ed-2ecc-4afc-a5c0-a76f00c320bc --><p><strong>Before</strong><strong> discussing the benefits and harms of treatment, or starting, </strong><strong>stopping </strong><strong>or switching antidepressant treatment during pregnancy, seek advice, ideally from a specialist perinatal mental health team, where available; or from a secondary mental health service; or the UK Teratology Information Service (UKTIS) on </strong><strong>0344 892 0909.</strong><strong> </strong></p><ul><li><strong>If an antidepressant is required in pregnancy: </strong><ul><li>The threshold for antidepressant prescribing should be adjusted compared with nonpregnant women because of the uncertain risks in pregnancy, and increased monitoring and support offered.</li><li>The choice of drug should be based on the woman's previous response to medication, the stage of pregnancy, and the risk profile for her and her fetus or baby.<ul><li>Note that no psychotropic medication has a UK marketing authorisation specifically for women who are pregnant or breastfeeding and informed consent should be obtained and documented.</li></ul></li><li>The lowest effective dose should be prescribed, but ensure that depression is adequately treated. Be aware that dosages may need adjustment during pregnancy.</li><li>The risk of discontinuation symptoms in the woman and neonatal adaptation syndrome in the baby with most tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors<strong> </strong>(SSRIs), and (serotonin-) noradrenaline reuptake inhibitors [(S)NRIs], in particular paroxetine and venlafaxine, should be taken into account.</li><li>A single drug should be used, if possible, rather than two or more drugs.</li></ul></li><li><strong>Risks of selective serotonin reuptake inhibitors (SSRIs):</strong><ul><li>In terms of malformation risk, a definite association between SSRI use in pregnancy and the occurrence of fetal malformation has not been confirmed.</li><li>Data for SSRIs as a class are conflicting and confounded. There is an indication from some studies that there may be a small increase in the absolute risk of cardiovascular malformations when a fetus is exposed to an SSRI during pregnancy, but other studies did not support this and meta-analyses did not confirm the association. There is a suggestion that confounding factors affecting women with the conditions for which SSRIs are indicated may account for the increased cardiac malformation rates in some studies. Other specific congenital malformations have been reported with SSRI use as a class in some studies, but these results have not been reproduced.</li><li>Some studies show an association between SSRI use in pregnancy and an increased risk of spontaneous abortion (odds ratio about 1.5), low birth weight, and preterm delivery, but data are conflicting and it is unclear how common these outcomes are. It is also possible that maternal depression may be a confounding factor as these outcomes have all been associated with this condition.</li><li>Persistent pulmonary hypertension has been found to be more likely to affect newborns exposed to SSRIs after 20 weeks of gestation compared with the general population, although the absolute risk is low (0.2–1.2% with SSRI exposure compared with 0.1–0.2%).</li><li>There are conflicting data on neurodevelopmental impairment after maternal SSRI use in pregnancy and there were methodological limitations to some of the studies therefore more information is needed. Autism spectrum disorder has been associated with SSRI use in pregnancy, but this may also be associated with the mother's underlying condition and more evidence is needed. </li><li>Transient neonatal withdrawal syndrome can affect infants exposed to SSRIs in the weeks leading up to delivery and can cause central nervous system, motor, respiratory, and gastrointestinal symptoms.</li><li>Serotonin-blocking antidepressants may increase the risk of postpartum haemorrhage, but the size and significance of this risk is not clear.</li></ul></li><li><strong>Risks of tricyclic antidepressants (TCAs)</strong><ul><li>Data do not show strong evidence that TCAs as a class are associated with an overall increased risk of congenital malformations, however, information is limited on specific TCAs, meaning an increased risk of malformations cannot be completely excluded. Cardiac malformations may be associated with exposure to clomipramine, but this has not been confirmed. </li><li>Although data are conflicting, there is a possible association with TCA use in pregnancy and preeclampsia, spontaneous abortion, preterm delivery and autism spectrum disorder.</li><li>Neonatal withdrawal symptoms and/or poor neonatal adaptation syndrome may also be associated with TCA use throughout pregnancy or close to delivery.</li></ul></li><li><strong>Risks of </strong><strong>(serotonin-) noradrenaline reuptake inhibitors [(S)NRIs]</strong><strong><strong>,</strong> for example, duloxetine and venlafaxine: </strong><ul><li>There are very limited data available on the use of duloxetine in pregnancy, therefore, its use would not be routinely recommended. If venlafaxine use is being considered in pregnancy UKTIS recommend the case is discussed with them and the woman carefully counselled. </li><li>(S)NRIs share similar properties with SSRIs which are associated with an increased risk of persistent pulmonary hypertension of the newborn. </li><li>Neonatal problems observed in infants exposed to (S)NRIs in utero are similar to those reported with SSRIs and include irritabilty, tremor, muscle weakness, difficulty sucking, respiratory problems, low apgar score, hypoglycaemia, and convulsions. The neonate should be monitored for adverse effects post-delivery. </li></ul></li><li><strong>For information regarding the risks of using specific antidepressant drugs in pregnancy, </strong>see the individual monographs available from the UK Teratology Information Service at <a href="http://www.uktis.org/" data-hyperlink-id="c3190e79-b2af-4035-bc15-a98f0114aee1">www.uktis.org</a>. Detailed summaries of the risks associated with these drugs are available on the Toxbase website <a href="https://www.toxbase.org/" data-hyperlink-id="40d2f32c-8ff9-43df-b044-a98f0114af2a">www.toxbase.org</a>; access to the the website is free to health care professionals; however, registration is required.<strong> </strong></li></ul><!-- end field b90609ed-2ecc-4afc-a5c0-a76f00c320bc --><!-- end item 41b1f2e7-0932-455f-93b0-a76f00c31ecf --></div><section aria-labelledby="basis-for-recommendation-7dc" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-7dc">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 7dc157ce-3148-438f-a436-a76f00c320c0 --><!-- begin field 3dd0f03a-0795-49e8-8f13-a76f00c320c0 --><h5>Seeking specialist advice</h5><ul><li>This recommendation is extrapolated from the opinion of the National Institute for Health and Care Excellence (NICE) that advises considering seeking advice, preferably from a specialist perinatal mental health service, when more detailed advice about risks of mental health problems or the benefits and harms of treatment in pregnancy is needed, or when psychotropic medication is started in pregnancy [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]. It is also extrapolated from an evidence review commissioned by NICE that noted that considerable caution should be used when changing or stopping antidepressant drugs in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li><li>Seeking specialist advice is also recommended due to the uncertainty regarding the benefits, risks and potential harms of mental health treatments in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>], the fact that the UK Teratology Information Service (UKTIS) does not make specific recommendations on the 'safest' antidepressants in pregnancy, the fact that there are no antidepressants licensed for use during pregnancy (although the use of antidepressants during pregnancy is common) [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>] and the opinion of the NICE guideline development group that specialist knowledge is required when assessing the trade-off of the benefits and harms of psychotropic medication for mental health problems in pregnancy and the postnatal period [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>].</li><li>NICE advises that when choosing an antidepressant, prescribers should be aware that their safety in pregnancy and breastfeeding is not well understood [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>] </li></ul><h5>Choice of drug and prescribing advice in pregnancy</h5><ul><li>This recommendation is based on the NICE publication <em>Antenatal and postnatal mental health: clinical management and service guidance</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. <ul><li>An evidence review commissioned by NICE outlined the complexities of making decisions about psychotropic medicine use during pregnancy and in breastfeeding on an individual basis, taking into account the woman's stage of pregnancy and, in particular, the risk of severe episodes of mental illness in relation to childbirth, the consequences for her family, the reproductive safety of medication and background risks of malformation, and the risk of neonatal withdrawal [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li></ul></li><li>The advice to prescribe the lowest effective dose also reflects Canadian best practice guidelines [<a class="bibliography-reference internal-reference" href="../../references/index.html">BC Reproductive Mental Health Program, 2014</a>] and the opinion of the UK Teratology Information Service (UKTIS) [<a class="bibliography-reference internal-reference" href="../../references/index.html">UKTIS, 2017</a>].  </li><li>A British Association for Psychopharmacology consensus guideline advises generally avoiding switching medication in pregnancy unless the benefit outweighs the risks, and that the most important information about the efficacy of a drug for a particular woman is based on her own treatment history. If a woman has previously had a good response to a medication, there should be a good reason not to recommend it or to use a drug with unknown efficacy, even if it has a lower risk in pregnancy [<a class="bibliography-reference internal-reference" href="../../references/index.html">McAllister-Williams et al, 2017</a>].</li></ul><h5>Risks of selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and (serotonin-) noradrenaline reuptake inhibitors [(S)NRIs]</h5><ul><li>This information is largely based on a review of the available data by the UKTIS on the use of SSRIs, TCAs and (S)NRIs (duloxetine and venlafaxine) during pregnancy [<a class="bibliography-reference internal-reference" href="../../references/index.html">UKTIS, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">UKTIS, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">UKTIS, 2018a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">UKTIS, 2018b</a>].<ul><li>UKTIS is recommended as a good source of information on specific drug use in pregnancy by a systematic review of recognition and management of perinatal depression and anxiety by general practitioners [<a class="bibliography-reference internal-reference" href="../../references/index.html">Ford et al, 2017</a>]. </li></ul></li><li>Information is also consistent with discussion of risks of SSRI and (S)NRI use in pregnancy in British Association for Psychopharmocology consensus guidance [<a class="bibliography-reference internal-reference" href="../../references/index.html">McAllister-Williams et al, 2017</a>], Canadian consensus guidelines [<a class="bibliography-reference internal-reference" href="../../references/index.html">MacQueen et al, 2016</a>], Medicines and Healthcare products Regulatory Agency guidance [<a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2014</a>], and meta-analyses of cohort and case-control studies [<a class="bibliography-reference internal-reference" href="../../references/index.html">Mezzacappa et al, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Zhang et al, 2017</a>].</li></ul><!-- end field 3dd0f03a-0795-49e8-8f13-a76f00c320c0 --><!-- end item 7dc157ce-3148-438f-a436-a76f00c320c0 --></div></section></section><section aria-labelledby="follow-up" class="ChapterBody-module--wrapper--2HCfk "><h3 id="follow-up">How should I follow-up a pregnant woman with depression?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item d8d059dc-ff06-45de-aa47-a770008cf76a --><!-- begin field 532946e8-8751-46c6-9b95-a770008cfacc --><ul><li><strong>When following up a woman with depression in the antenatal or postnatal periods:</strong><ul><li>Assess and agree the level of contact and support needed. </li><li>Regularly monitor for symptoms during pregnancy and the postnatal period, particularly in the first few weeks after childbirth. </li><li>At all contacts, consider asking the two <a class="topic-reference internal-reference" href="../../diagnosis/detection/index.html">depression identification questions</a> as part of a general discussion about her mental health and wellbeing and using the Edinburgh Postnatal Depression Scale (EPDS) or the Patient Health Questionnaire (PHQ-9) as part of monitoring.<ul><li>At each postnatal contact, ask about the woman's emotional wellbeing, what family and social support they have and their usual coping strategies for dealing with day-to-day matters. Encourage women and their families/partners to tell their healthcare professional about any changes in mood, emotional state and behaviour that are outside of the woman's normal pattern. </li></ul></li><li>Discuss how her symptoms will be monitored, for example by using validated self-report questionnaires, such as the EPDS or PHQ-9. </li><li>If a woman is on drug treatment, review frequently, with dose adjustment if necessary.</li><li>Encourage postnatal women to help look after their mental health by looking after themselves, for example, taking gentle exercise, resting, seeking help with caring for the baby, and talking to someone about how they are feeling. </li></ul></li></ul><!-- end field 532946e8-8751-46c6-9b95-a770008cfacc --><!-- end item d8d059dc-ff06-45de-aa47-a770008cf76a --></div><section aria-labelledby="basis-for-recommendation-b00" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-b00">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item b00997bc-913b-47f7-93dc-a770008cfad1 --><!-- begin field 38eaae25-fe4d-4c4e-8caf-a770008cfad1 --><ul><li>These recommendations are based on the National Institute for Health and Care Excellence (NICE) publications <em>Antenatal and postnatal mental health</em> <em>(clinical management and service guidance) </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>] and <em>Postnatal care up to 8 weeks after birth </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2006</a>]. The recommendation about frequent review of drug treatment is based on a consensus article on perinatal depression and anxiety [<a class="bibliography-reference internal-reference" href="../../references/index.html">Kendig et al, 2017</a>]. <ul><li>The recommendations are also supported by an evidence review commissioned by NICE which discussed that monitoring of the effects of interventions should be a continual process and incorporated into routine care, where possible [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2014</a>]. </li></ul></li></ul><!-- end field 38eaae25-fe4d-4c4e-8caf-a770008cfad1 --><!-- end item b00997bc-913b-47f7-93dc-a770008cfad1 --></div></section></section></section></div></div></div><div class="BackToTop-module--wrapper--2Z0EU"><nav aria-labelledby="back-to-top-link" class="BackToTop-module--nav--1DPZ6"><a class="BackToTop-module--anchor--1Nia6" id="back-to-top-link" href="index.html#content-start"><div class="container"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="icon" aria-hidden="true" focusable="false"><path d="M478.152 338.576c0 10.091-3.525 18.661-10.576 25.712l-21.424 21.424c-7.243 7.243-15.909 10.864-26 10.864-10.283 0-18.853-3.621-25.712-10.864L255.576 247.136 116.712 385.712c-6.859 7.243-15.429 10.864-25.712 10.864s-18.853-3.621-25.712-10.864l-21.424-21.424C36.621 357.429 33 348.859 33 338.576c0-10.091 3.621-18.757 10.864-26l186-186c7.051-7.051 15.621-10.576 25.712-10.576 9.909 0 18.576 3.525 26 10.576l185.712 186c7.243 7.243 10.864 15.909 10.864 26z" fill="currentColor"></path></svg> Back to top</div></a></nav></div></main><footer class="Footer-module--footer--2QrGZ"><div class="Footer-module--container--1iuoB"><a href="https://www.nice.org.uk/" class="Footer-module--logo--3DGKv" aria-label="Go to NICE home page"></a><nav class="Services-module--wrapper--2qOoE" aria-label="Our services"><ul class="Services-module--list--3SZQu"><li><a href="https://pathways.nice.org.uk/" class="Services-module--link--2y_1q">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Services-module--link--2y_1q">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Services-module--link--2y_1q">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Services-module--link--2y_1q">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary">BNF<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Services-module--link--2y_1q"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Services-module--visuallyHidden--t9mfm">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">Clinical Knowledge Summaries</span></a></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Services-module--link--2y_1q">Journals and databases</a></li></ul></nav><nav class="Pages-module--wrapper--30REl"><ul class="Pages-module--list--vvSk4"><li><a href="https://www.nice.org.uk/about">About NICE</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/into-practice">Into practice</a></li><li><a href="https://www.nice.org.uk/get-involved">Get involved with NICE</a></li><li><a href="https://www.nice.org.uk/get-involved/jobs">Jobs</a></li><li><a href="https://www.nice.org.uk/news">News</a></li><li><a href="https://www.nice.org.uk/news/nice-newsletters-and-alerts">Newsletters and alerts</a></li><li><a href="https://www.nice.org.uk/get-involved/contact-us">Contact us</a></li><li><a href="https://www.nice.org.uk/leave-feedback">Leave feedback</a></li><li><a href="https://www.nice.org.uk/re-using-our-content">Reusing our content</a></li><li><a href="https://www.nice.org.uk/re-using-our-content/uk-open-content-licence">NICE UK Open Content Licence</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/nice-syndication-api">Syndicate our content</a></li></ul></nav><div class="Social-module--wrapper--2nKsd"><ul class="Social-module--list--E5R5J" aria-label="NICE on social media"><li><a href="https://en-gb.facebook.com/NationalInstituteforHealthandCareExcellence/">Facebook</a></li><li><a href="https://twitter.com/NICEcomms">Twitter</a></li><li><a href="https://www.youtube.com/user/NICEmedia">YouTube</a></li><li><a href="https://www.instagram.com/nicecomms/">Instagram</a></li><li><a href="https://www.linkedin.com/company/national-institute-for-health-and-clinical-excellence">LinkedIn</a></li></ul></div></div><div class="Legal-module--wrapper--3AYMO"><div class="Legal-module--container--3TTBh"><nav class="Legal-module--menu--1e1Iy" aria-label="Legal menu"><ul><li><a href="https://www.nice.org.uk/accessibility">Accessibility</a></li><li><a href="https://www.nice.org.uk/freedom-of-information">Freedom of information</a></li><li><a href="https://www.nice.org.uk/glossary">Glossary</a></li><li><a href="https://www.nice.org.uk/terms-and-conditions">Terms and conditions</a></li><li><a href="https://www.nice.org.uk/privacy-notice">Privacy notice</a></li><li><a href="https://www.nice.org.uk/cookies">Cookies</a></li></ul></nav><p class="Legal-module--copyright--34nsI">©<!-- --> <abbr title="National Institute for Health and Care Excellence">NICE</abbr> <!-- -->2021<!-- -->. All rights reserved. Subject to<!-- --> <a href="https://www.nice.org.uk/terms-and-conditions#notice-of-rights">Notice of rights</a>.</p></div></div></footer></div><div id="gatsby-announcer" style="position:absolute;top:0;width:1px;height:1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);white-space:nowrap;border:0" aria-live="assertive" aria-atomic="true"></div></div><script id="gatsby-script-loader">/*<![CDATA[*/window.pagePath="/topics/depression-antenatal-postnatal/management/pregnant-on-an-antidepressant/";/*]]>*/</script><script id="gatsby-chunk-mapping">/*<![CDATA[*/window.___chunkMapping={"polyfill":["/polyfill-2cb897c2a056d28c9332.js"],"app":["/app-53a71c38b210970893c4.js"],"component---cache-caches-gatsby-plugin-offline-app-shell-js":["/component---cache-caches-gatsby-plugin-offline-app-shell-js-258fa972005c75a2a109.js"],"component---src-pages-404-tsx":["/component---src-pages-404-tsx.4b20f8dadfa146d0f95d.css","/component---src-pages-404-tsx-db046304e34e9a4e982b.js"],"component---src-pages-about-development-tsx":["/component---src-pages-about-development-tsx.4c5b5dd941fb0f6fd929.css","/component---src-pages-about-development-tsx-a805dcaba6372bd3fd34.js"],"component---src-pages-about-index-tsx":["/component---src-pages-about-index-tsx.a9a4b7f951b698486005.css","/component---src-pages-about-index-tsx-d5e998d3f688352286e1.js"],"component---src-pages-index-tsx":["/component---src-pages-index-tsx.49dafffcf9ae0c5f0d9f.css","/component---src-pages-index-tsx-6cc2ff789de11ec327f6.js"],"component---src-pages-search-tsx":["/component---src-pages-search-tsx.f915457cd8b05c27e895.css","/component---src-pages-search-tsx-a51f99760cb0d47808e2.js"],"component---src-pages-specialities-tsx":["/component---src-pages-specialities-tsx.fc62cf637c7ba1e609e7.css","/component---src-pages-specialities-tsx-90b8d3e5a5a3bff52a17.js"],"component---src-pages-topics-tsx":["/component---src-pages-topics-tsx.dfa0c1027e3cbeb11bdc.css","/component---src-pages-topics-tsx-960f75c13acbee11c017.js"],"component---src-pages-whats-new-tsx":["/component---src-pages-whats-new-tsx.7f7660f22ce5e07ac85a.css","/component---src-pages-whats-new-tsx-f78b713a66b42005fd9f.js"],"component---src-templates-chapter-level-1-chapter-level-1-tsx":["/component---src-templates-chapter-level-1-chapter-level-1-tsx.1a16ce552cccd7e50c41.css","/component---src-templates-chapter-level-1-chapter-level-1-tsx-0a03778bb80ba711929e.js"],"component---src-templates-chapter-level-2-chapter-level-2-tsx":["/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css","/component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"],"component---src-templates-speciality-speciality-tsx":["/component---src-templates-speciality-speciality-tsx.fc62cf637c7ba1e609e7.css","/component---src-templates-speciality-speciality-tsx-3357943d471e489a1b5f.js"],"component---src-templates-topic-topic-tsx":["/component---src-templates-topic-topic-tsx.afc04214919e241c3c2e.css","/component---src-templates-topic-topic-tsx-f17fe03d0b9a54a96aea.js"]};/*]]>*/</script><script src="../../../../polyfill-2cb897c2a056d28c9332.js" nomodule=""></script><script src="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js" async=""></script><script src="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js" async=""></script><script src="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js" async=""></script><script src="../../../../app-53a71c38b210970893c4.js" async=""></script><script src="../../../../framework-34da02e39e1f104d9937.js" async=""></script><script src="../../../../webpack-runtime-28c424ef71f39faedaf0.js" async=""></script></body></html>